May 2011 - ATS News - American Thoracic Society

dean e. schraufnagel, md President
nicholas s. hill, md President-Elect
j. randall curtis, md, mph Past President
monica kraft, md Vice President
patricia finn, md Secretary-Treasurer
stephen c. crane, phd, mph Executive Director
brian kell Senior Director, Communications & Marketing
suzy logan Senior Manager, Communications &
Marketing / Editor
p2
p4
p5
p6
in this issue
HealtH
leadersHip
The ATS 2011 President’s
Symposium will highlight
global initiatives and strategies
aimed at reducing the burden
of lung diseases.
spotligHt on
Committees
Marc Moss, MD, talks
about what the Society is
doing to improve the ATS
International Conference
experience for attendees.
The ATS is solely responsible for all content. Questions
and comments may be addressed to Suzy Logan at
slogan@thoracic.org.
Vol. 37 No. 5 May 2011 ATS News (issn 0892-8916) is published
monthly at 61 Broadway, New York, NY 10006. Copyright 2011 by
the American Thoracic Society.
REgiStER foR
AtS 2011 todAy!
Visit http://conference.
thoracic.org for details
WHo’s WHo
at ats
Debra Weese-Mayer, MD,
is revolutionizing pediatric
respiratory medicine at
the Children’s Memorial
Hospital in Chicago.
neW statement
on ips
The ATS has published a
new statement on idiopathic
pneumonia syndrome that
reviews both preclinical and
clinical findings.
NEWS
o n l i n e e a c h m o n t h http://www.thoracic.org/go/news
ATS STATemenT IdenTIfIeS PrImAry
feATureS of ALI In LAb AnImALS
The ATS has released a report that appears in the May 1, 2011, issue of the American
Journal of Respiratory Cell and Molecular Biology, which identifies the primary features
of acute lung injury (ALI) in animals.
The report summarizes the recommendations of the ATS
Acute Lung Injury in Animals Study Group, and although
it falls short of offering a consensus definition of ALI in
animals, it is a critical first step toward that goal, according
to Gustavo Matute-Bello, MD, associate professor of
medicine at University of Washington’s Center for Lung
Biology and co-chair of the study group.
“The original goal of the committee was to draft a
consensus definition of acute lung injury in animals,” Dr.
Matute-Bello said. “However, it soon became obvious that
this issue is so controversial that we would be unable to
reach a consensus; therefore, we opted to identify the main
features of acute lung injury in animals. Our hope is that
this will be the first step toward a definition.”
An accepted definition of lung injury in animal
models would have important clinical implications and
would enable study results to be compared in a meaningful
way, Dr. Matute-Bello said.
“There is no consensus in the scientific community
as to what exactly constitutes ALI in an animal, in part
because there is no single marker or parameter that
has sufficient sensitivity and specificity to identify the
occurrence of all forms and severities of ALI,” he said. “As
a result, many authors define it differently, and research
conclusions such as ‘drug A attenuated lung injury in
mice’ are very difficult to interpret. Furthermore, data
cannot be compared between studies. We believe that these
difficulties have impaired the translation of experimental
studies into improvements in bedside care. Our work
was an attempt to initiate an effort toward bringing some
agreement as to what is experimental lung injury.”
In humans, the definition of ALI is based on the
following well-defined set of clinical parameters developed
by the American European Consensus Conference: acute
onset, radiological evidence of diffuse bilateral pulmonary
infiltrates, a ratio of the partial pressure of arterial oxygen
to the fraction of inspired oxygen (PaO 2 /FIO 2 ) of less
than 300, and no clinical evidence for elevated pulmonary
arterial pressure.
However, these criteria cannot be directly translated
to experimental animals. Although arterial blood gases,
chest radiographs, cardiac echocardiography and even
catheterization can be performed in small experimental
animals, the equipment required for these measurements is
available only in a few laboratories and the measurements
may be incompatible with the design of many experimental
systems. These factors make it impractical to apply the
American European Consensus Conference criteria to
animal studies, particularly those of small animals, Dr.
Matute-Bello said.
This report examines the main features of human
ALI that are being modeled in animals, describes the
methodology used to identify the defining features of
lung injury in animals, discusses common methods of
measuring lung injury, critically assesses standard models
of lung injury and discusses the limitations of this
approach, Dr. Matute-Bello added.
“Perhaps the most significant issue addressed in this
report is the recommendation that a multidimensional
approach be used to identify acute lung injury, by taking
into account multiple domains, such as histological
evidence of tissue injury, alteration of the alveolar capillary
barrier, an inflammatory response, and some evidence of
physiological dysfunction,” said he explained. The full
report can be viewed online at http://ajrcmb.atsjournals.
org/current.dtl.
background image
© iStockPhoto
1
Background photo © iStockPhoto

2
NEWS
dean E. Schraufnagel, Md
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
This will be my last president’s report, as we get ready for the ATS International Conference and a changing of ATS
officers. Dr. Nicholas Hill will become president at the Denver meeting. He is a great leader who will guide the ATS
well. For me, the year has gone by quickly. I have been amazed at how many good things the ATS is doing and have
really appreciated the opportunity to serve in a leadership position. I thank the wonderful members, staff and nonmember
partners who carry out ATS activities and have been so helpful to me. Next year, as immediate-past president,
I will continue working on a number of projects for our members.
Much of my work this year entailed working on policies, looking for opportunities for projects, papers or
our members, and interacting with other societies to improve, or at times maintain, the lives of our patients and
professionals. Advocacy is a significant part what the ATS does; this year, our government relations office responded to
the threats of changes in healthcare, funding of research and protection of the environment. Much of this work is done
by our hard-working committees, to which we owe our gratitude.
I am looking forward to the 2011 ATS International Conference. In addition to the educational programs, the
assemblies and most committees will meet to wrap up the work they have done over the past year and prepare for the
next. The Council of Chapter Representatives will meet to discuss the challenges of running chapters and how they
contribute to the ATS as a whole. This is a good time to become involved if you wish. It can be very rewarding to
work on projects that will advance respiratory health. Involvement also offers an opportunity to meet and work with
colleagues from different settings and to help or be helped by someone. In the process, you will get to know your fellow
members better, which in itself is rewarding.
Again, thanks for choosing me to be your president. I look forward to working with the ATS for many years
to come.
president’s symposium to address
global HealtH leadersHip
The ATS 2011 President’s Symposium will focus on developing global
health leadership, an area of increasing importance as global trade and
the ease of travel have broken down national boundaries with respect to
respiratory diseases, critical illnesses and sleep disorders. The symposium
will take place on Monday, May 16, from 8:15 to 10:45 a.m., in the Korbel
Ballroom 2A-3A on the lower level of the Colorado Convention Center.
“This symposium will focus on leadership in world health: how to be a leader, how to find a leader and how to
develop a leader,” said ATS President Dean E. Schraufnagel, MD, who will co-chair the program with ATS President-
Elect Nicholas S. Hill, MD.
Leaders from the National Institutes of Health, World Bank and World Health Organization’s Stop TB
Partnership will discuss the definition, nature and impact of leadership. They will also talk about how to deal with
difficult situations in various international settings, as well as suggest ways for individuals to become more involved
and effective in the international projects in which they are involved.
“Almost half of attendees who attend the ATS International Conference come from outside the United States and
many North American attendees are involved in international activities,” Dr. Schraufnagel explained. “Many participants
are or aspire to be international global health leaders and are involved in developing and training future leaders.”
During the program, Lucica Ditiu, MD, executive secretary of the WHO Stop TB Partnership, will discuss her
efforts to treat TB in the Balkans. “If we think we have difficulties getting people to work together, we need to listen
to Dr. Ditiu tell how she tried to develop a team approach to treating tuberculosis in the Balkans during their civil
war,” Dr. Schraufnagel said.
The session will also educate attendees about international organizations, how they view leadership, and how they
select and train leaders. “Effective leadership makes all the difference,” Dr. Schraufnagel continued. (continued on page 16)
NEWS
BRIEFS
‘Road Map’ & Guide to
HigHligHt Best of Ats 2011
This year, the Society has produced two
publications to help ATS International
Conference attendees to navigate ATS
2011: one for individuals at the beginning
of their careers, and the other for members
of the interdisciplinary team.
For the fifth consecutive year, the ATS
Members In Transition and Training
Committee will publish the Road Map
for Fellows & Junior Professionals, which will highlight
sessions and other events of interest at ATS 2011, so that
new members and first-time conference attendees get the
most out of the meeting’s 500 sessions, 1,000 speakers and
5,400-plus original research abstracts and case reports.
The Society will also launch the Interdisciplinary Team
(IDT) Conference Guide, a new publication for nurses, PTs,
RNs, PAs and RRTs. Produced by the ATS interdisciplinary
team working group, the guide will list sessions, symposia,
workshops and courses of interest to these healthcare
professionals.
Hardcopies of both publications will be available onsite
during the International Conference at the ATS Center,
Center for Fellows and Junior Professionals and Clinicians
Center, as well as at the 13 assembly membership
meetings. Attendees can also download the Road Map
and IDT Guide by visiting http://conference.thoracic.org.
5K lung Run
At Ats 2011
During the 2011 ATS International
Conference in Denver, support
fitness and lung health at the 5K
Lung Run & Walk. On the morning
of Sunday, May 15, participants will
take in the city’s scenic beauty as they run along the Platte
River trails located in lower downtown Denver. Kicking off at
Cuernavaca Park, one of nine parks named after Denver’s
sister cities and conveniently located within 10 minutes of
the Colorado Convention Center, this year’s Run & Walk
will not only start your day on the right foot, but it will offer
a spectacular view of the Rocky Mountains and Denver’s
skyline as well.
The $30 entry fee includes transportation from the Colorado
Convention Center, timing chips and bibs, refreshments
and online race results. Top finishers will also receive
additional recognition. Attendees can register in advance by
visiting www.conventiondesigns.com/eventRegistration.
aspx?eCode=Ats20115K. All participants will be required
to sign a waiver onsite.
Be tHe fiRst to Know
Have the table of contents of the ATS’s journals
e-mailed to you each month. To sign up, please
visit www.thoracic.org/journals/index.php
and click on “e-TOC” under
the journal of your choice.
ats news | vol.37 no.5 | may 2011

NEWS
FiFtH annual ‘breatHing better’ event stresses
patient empoWerment
On Saturday, May 14,
the Society’s Public
Advisory Roundtable
(PAR) will host will
host its fifth annual
“Breathing Better with
the ATS” forum, at
which attendees will
have the opportunity
to network with lung
disease patients, as well
as with clinicians and
researchers who specialize in the fields of pulmonary,
critical care and sleep medicine. The forum, which will
focus on patient empowerment, will take place from 1 to
4 p.m. at the Sheraton Denver Downtown Hotel. The
event is open to patients and their families, representatives
of public interest organizations, members of the media and
the general public.
This is the second year that the “Breathing Better
with the ATS” program will feature an additional segment
called “Meet-the-Experts.”
“Prior to the forum’s main talks commence in
the afternoon, patients will have the opportunity to
personally meet leading researchers and clinicians who
diagnose and treat a wide range of lung diseases, critical
illnesses and sleep disorders,” said Teresa Barnes, who is
chair of ATS PAR and vice president for patient outreach
and advocacy at the Coalition for Pulmonary Fibrosis.
“Patients are also encouraged to talk with one another
and share their experiences with lung disease.”
Some of the prominent ATS members who have
volunteered to meet patients at this event include:
Sleep apnea: Michael Coppola, MD
Pulmonary fibrosis: Greg Cosgrove, MD
Sarcoidosis: Robert Baughman, MD; Lisa Maier, MD,
MSPH; Daniel Culver, DO; Milton Rossman, MD
Hermansky-Pudlak syndrome:
Bernadette Gochuico, MD
Connect to the ATS
International Conference year
round with the online ATS Bulletin.
Explore the site today at
ats-365.ascendeventmedia.com.
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
Lung cancer: Fred R. Hirsch, MD, PhD
Children’s interstitial lung disease:
Robin Deterding, MD
At the “Breathing Better” forum, which begins at
1 p.m., five panelists will discuss ways in which patients
can become more empowered and take control of their
health.
Stephen Rennard, MD, of the University of Nebraska
Medical Center, will discuss new treatments on the horizon
from a host of lung diseases. “New therapies will include
better versions of what is already available, as well as new
treatments that will address problems that have not been
addressed before,” said Dr. Rennard, who is an expert on
COPD. “The COPD patient, for example, should hope
for a true cure that will restore lost function. Therapy will
become much more personalized, so that patients can
receive treatment that is tailored for their specific needs
and sensitivities.”
Jill Ohar, MD, of Wake Forest University Baptist
Medical Center, will speak about women and lung disease.
“While women are often regarded as the hysterical sex
by healthcare providers, there are several anatomic and
physiologic reasons why woman are affected by lung
diseases differently than men,” she noted. “Among these
reasons are size and differing growth, hormonal and
aging patterns.”
Other panelists include Keene Jorgensen, a COPD
patient-advocate for the Colorado Society for Respiratory
Care; Bart Celli, MD, of Brigham and Women’s Hospital,
who will talk about the prevalence of respiratory diseases
in the U.S. and around the world; and Gail Weinmann,
MD, of the National Heart, Lung, and Blood Institute,
who will discuss the need for more lung disease research.
“Research supported by the NHLBI and others today is
laying the groundwork for better treatments tomorrow,
just as today’s treatments are heavily based upon past
research,” Dr. Weinmann said.
The talks will be followed by a question-and-answer
session and a reception with refreshments.
20 ATS
COMPLETE
COVERAGE
2011
ATS
COMPLETE
COVERAGE
2011
ATS
LETE LETE AT
NEWS
BRIEFS
RemindeRs foR fACulty
At Ats 2011
ATS members who will
be serving as faculty for
CME-accredited sessions
at the Society’s 2011
International Conference
in Denver are reminded of
the importance of onsite
conflict of interest (COI)
disclosure and management.
In addition to completing a pre-conference disclosure
questionnaire, the ATS requires that all faculty speaking
at CME-accredited International Conference sessions
prepare and show disclosure slides at the beginning of
their presentation. These slides are specific to presentation
subject matter and ensure that the ATS complies with
Accreditation Council for Continuing Medical Education
(ACCME) requirements for disclosure to learners.
Instructions and PowerPoint disclosure slide templates
can be downloaded from the ATS Web site at http://
conference.thoracic.org/speakers/index.php.
Moderators and presenters can also retrieve a PDF of
their 2011 conference disclosures for use in preparing
these slides by logging back into their personal
conference disclosure account at https://thoracic.coismart.com.
Session chairs/moderators are also reminded to look
for the COI documentation form on the podium at their
sessions. They must complete the form by the end of
each session they moderate, in order for the ATS to
meet ACCME requirements for written attestation that
disclosure slides were shown, and of any other disclosures
made orally. Questions? Contact the ATS COI office at
coioffice@thoracic.org or (212) 315-8627.
Ats CenteR to Be loCAted
in exHiBit HAll
For the Society’s
2011 International
Conference, the ATS
Center will once again
move into the Exhibit
Hall in booth 1331
from Sunday, May 15
to Tuesday, May 17.
In addition to providing
information about the conference, the Center will feature
material on all of the Society’s educational and outreach
programs, from its journals to its international activities in
Africa and Asia. Attendees can also learn more about the
ATS, pick up free patient education materials, and, if they
are not already, become an ATS member.
The Center’s satellite location, which will be open
from Friday, May 13 to Wednesday, May 18, will be
adjacent to registration in the Colorado Convention
Center. Please check the 2011 Final Program for specific
hours of operation.
ats news | vol.37 no.5 | may 2011 3

4
NEWS
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
dEbRA E. WEESE-MAyER IS REvolutIoNIzINg
PEdIatRIc RESPIRatoRy MEdIcINE
With two older physician brothers, a dentist father, two uncles
and a grandfather in pharmacy, and a highly motivating mother,
it might seem like becoming a physician would have been an
obvious choice. But according to Debra E. Weese-Mayer, MD,
who as a teen aspired to be a judge, it was her grandmother who
had the greatest influence on her decision to become a doctor.
“In high school, my maternal grandmother underwent
two above-knee amputations for suboptimally-managed type
2 diabetes,” recalled Dr. Weese-Mayer, who is medical director
of the Children’s Memorial Hospital’s Center for Autonomic
Medicine in Pediatrics (CAMP) in Chicago. “Seeing her
suffering made it apparent that I needed to pursue a profession
in which I would be able to help people who truly needed
help. Ultimately, this led to my love of pediatrics. There is no
more pure need than that of a child—someone who has done
nothing that brought about her/his illness.”
In 1989, Dr. Weese-Mayer’s dedication to pediatric
patients led her to a position with Rush University Medical
Center (RUMC), where she and colleagues developed the
center for disorders of respiratory control and the sudden
infant death syndrome (SIDS) research program.
“RUMC built our animal and clinical laboratories, and
provided years of research support with excellent internal and
external collaboration,” said Dr. Weese-Mayer, who is also
professor of pediatrics at Northwestern University’s Feinberg
School of Medicine. “During 18-plus years at RUMC, we
were very successful in growing our program and obtaining
extramural funding. But eventually, we longed to transition
to our next level of inquiry: developing the first center for
autonomic medicine in pediatrics.”
That opportunity came in 2008, when Dr. Weese-Mayer
and her team returned to CMH to found the CAMP program.
“The vision of the center had been brewing since 1999,
when I woke up in the middle of the night on a family
vacation in Madrid and realized that ‘it all made sense,’”
Dr. Weese-Mayer recalled. “For the first time, I could
envision the inter-relationship between congenital central
hypoventilation syndrome (CCHS) and SIDS and a growing
list of other diseases that fell within the rubric of what we
now call respiratory and autonomic disorders of infancy,
childhood and adulthood (RADICA).”
“By 2001, we realized it was time to build an international
center specifically dedicated to autonomic medicine in
pediatrics,” she continued. “At that time, the concept of a
center that was wholly cross-silo was so outside the box that
there were no borders visible. But as colleagues embraced the
concept, our momentum grew. Gratefully, the leadership at
CMH appreciated the vision and understood the revolutionary
concept that had never been developed in pediatrics. So in
early 2008, we moved to CMH to build the first CAMP. As an
aside, though the program’s focus is respiratory and autonomic
medicine, the acronym “CRAMP” was not nearly so catchy!”
Dr. Weese-Mayer said the goal of CAMP is to provide
an integrated program that looks at the “whole child,”
employing an array of tests, including a battery of child-
friendly, non-invasive autonomic exams to determine the
severity of involvement of all organ systems served by the
autonomic nervous system (ANS).
“Taken together, CAMP provides objective assessment of
all systems affected by the ANS, ascertains how to optimize the
child’s well-being and neurocognitive outcome, and provides
measures for after-discharge management,” she explained.
“Our team works with the child’s local physicians, many of
whom are experts in other pediatric disciplines, to provide a
cohesive plan for care. Families that have come to CAMP leave
with furthered knowledge about their child and her/his needs.”
In 2005, Dr. Weese-Mayer received the March of
Dimes Jonas Salk Health Leadership Award for her research.
More recently, she and her colleagues obtained a patent for
a diagnostic PHOX2B genetic test that screens for CCHS,
available exclusively at RUMC; then they donated the patent to
The Chicago Community Trust Foundation to further CCHS
research. Dr. Weese-Mayer has built an extraordinary team
and network of collaborators who collectively are embarking
on advanced studies focused on SIDS, stillbirth, rapid-onset
obesity with hypothalamic dysfunction, hypoventilation,
and autonomic dysregulation (ROHHAD), CCHS, Rett
syndrome and familial dysautonomia. “We firmly believe that
through study of these rare diseases we will develop a clearer
understanding of the basic underpinnings of the ANS—with
applicability to health and disease.”
Dr. Weese-Mayer joined the ATS in 1985, received
initial funding from ALA/ATS, and served as chair of both
the Assembly on Pediatrics Nominating Committee and
the writing committee charged with developing the ATS
statement on CCHS in 1999 and again in 2010.
“Those two statements have served families and
physicians of children with CCHS to seek and receive optimal
care,” she said. “Now, as a member of the ATS Foundation
Board of Trustees, it is a privilege to ensure that the next
generation is adequately supported so that they, too, can
become leaders based on their research foothold at the ATS.”
When not immersed in her work, Dr. Weese-Mayer enjoys
traveling with her “remarkable” husband Robert N. Mayer, PhD,
who is president of the Hulda B. and Maurice L. Rothschild
Foundation, and, when possible, their “awesome” children:
Jennifer, 29, a large animal veterinarian; Jaimie, 27, a director/
producer; Jonathan, 24, a computer science/law school graduate
student; and Hap, 31, an investment research analyst.
NEWS
BRIEFS
ATS • 2011 WebcASTS
As a benefit of your 2011 International Conference
registration, the ATS is again offering 12 months of free
access to 2011 conference Webcasts. Full conference paid
registrants will have post-meeting access to more than 200
hours of ATS 2011 presentations, reflecting the diverse
topic areas of the conference—including major symposia in
clinical, basic, translational and behavioral science, and all
Year in Review sessions at no extra charge.
Please note that free access is limited to paid conference
registrants in full conference categories (including
in-training). One-day registrants, other attendees and nonattendees
may pay for this 12-month access by placing
orders at designated pricing levels to be announced in the
final program onsite.
The “Best of ATS Conferences” Webcasts provide full
audio and slides, synchronized and searchable. More
details will be provided onsite during the meeting and will
be available on the Society’s Web site afterward. Visit
www.thoracic.org and click on “Best of ATS Conferences”
in the “education” drop-down menu.
Ats gRAnts 20 tRAvel AwARds
to Residents
In April, the ATS awarded 20 internal medicine and
pediatric residents a stipend of $1,000 to travel to the
2011 International Conference in Denver. Supported by an
educational grant from Merck, the ATS Resident Trainee
Travel Award (RTA) program is just one way the Society is
addressing the growing U.S. shortage of physicians in the
fields of pulmonary and critical care medicine.
The ATS will also provide recipients with complimentary
registration for ATS 2011 and one year of in-training ATS
membership. To ensure awardees get the most out of ATS
2011, each resident will bring a mentor to the International
Conference, who will personally guide them through the
many educational and networking opportunities.
To view the list of awardees, please visit http://thoracic.
org/education/career-development/2011-travel-awards.php.
mttA AwARdees to Be
HonoRed At diveRsity foRum
Last month, the ATS awarded 20 trainees who are
members of groups defined by the National Institutes of
Health as underrepresented minorities Minority Trainee
Travel Awards (MTTAs) for the 2011 ATS International
Conference in Denver.
Organized by the Membership and Training Committee
and supported by an educational grant from Merck, the
MTTA program aims to interest minority trainees in clinical,
research and academic careers in respiratory medicine by
providing them with $1,425 travel scholarships to attend
the annual ATS meeting. Attendees will also receive one
year of ATS in-training membership and will be recognized
at the 2011 Diversity Forum, also supported by Merck, on
Monday, May 16, at 11:30 a.m.
To view the list of awardees, please visit www.thoracic.
org/education/career-development/2011-travel-awards.php.
ats news | vol.37 no.5 | may 2011

NEWS
The ATS has published
a new report on
idiopathic pneumonia
syndrome (IPS) which
offers a comprehensive
review of both
preclinical and clinical
findings that may help
identify the causes of
IPS. The report was
prepared by an ad hoc
subcommittee of the
ATS Assembly on Respiratory Cell and Molecular Biology
and appears in the May 1, 2011, issue of the American
Journal of Respiratory and Critical Care Medicine.
The report is designed to impact clinical and
basic researchers who study non-infectious post-
HSCT pulmonary complications, as well as clinicians
who take care of patients with such complications,
according to Angela Panoskaltsis-Mortari, PhD, associate
professor of pediatrics and medicine at the University of
Minnesota’s Masonic Cancer Center, who chaired the ATS
subcommittee.
“Acute lung dysfunction of non-infectious
etiology, known as idiopathic pneumonia syndrome, is
a severe complication following hematopoietic stem cell
transplantation (HSCT),” Dr. Panoskaltsis-Mortari said.
“Several mouse models have been recently developed to
determine the underlying causes of IPS. This report offers
the first compilation of those mouse model studies aimed
at understanding IPS.”
“The goal was to review and consolidate the literature
to present a consensus view of how the various forms
of the disease can be categorized; how the various
mouse models that have been developed have helped to
inform the pathways that may be operative in the human
disease; the current understanding of IPS as a process
involving both adaptive and innate immune responses;
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
neW ats report FoCuses on possible Causes oF ips NEWS
and what future directions look promising and/or should
be pursued,” she said.
The report matches mouse models for specific
subtypes of human IPS disease based on histologic
patterns, she added.
In addition, Dr. Panoskaltsis-Mortari said the report
includes an updated definition of IPS that will be useful
to clinicians, and also recommends that IPS be classified
into specific entities, which may help determine which
patients will respond best to new therapeutic agents as
they become available.
“We expect that the statement will also help inform
researchers in the field as they devise the best approaches
to pursue in the study of causes and treatments of IPS and
which models to use,” she said.
The report supports a shift away from the current
paradigm, in which non-infectious lung injury after HSCT
is viewed simply as an idiopathic clinical syndrome and
toward a process in which the lung is the target of a
complex cytotoxic and immune-mediated attack.
“Significant research efforts have resulted in a
paradigm shift away from identifying non-infectious lung
injury after HSCT solely as an idiopathic clinical syndrome
and toward understanding IPS as a process involving
aspects of both the adaptive and the innate immune
response,” she noted. “Experimental models of IPS that
mimic the various patterns of lung injury observed after
HSCT have identified that both soluble and cellular
inflammatory mediators contribute to the inflammation
engendered during the development of IPS.
“To date, 10 pre-clinical murine models of the
IPS spectrum have been established based on models
used to study graft-versus host disease (GVHD),”
Dr. Panoskaltsis-Mortari added. “This, as well as the
demonstrated T-cell dependency of IPS development
in these models, supports the concept that the lung is
a target of immune-mediated attack after HSCT. The
(continued on page 15)
ATS Thanks Genentech & Novartis
for Generous Support of
ATS 2011 Fellows Symposium
The ATS will once again host a symposium that
will provide fellows with an orientation to the 2011
International Conference in Denver. Thanks to
educational grants from Underwriting Supporters
Genentech and Novartis, the ATS has offered first-, second- and third-year fellows from
125 U.S. training programs awards of $1,425 to travel to ATS 2011.
To view a list of all of the awardees, please visit
http://conference.thoracic.org/programs/fellows-track-symposium.php.
BRIEFS
CAll foR
PRoPosAls
The ATS is now accepting
proposals for the 2012
International Conference,
which will be held May 18
to 23, in San Francisco,
California. Proposals for
sessions covering all areas of
pulmonary, critical care and
sleep medicine are encouraged.
Submission formats include scientific symposia, seminars,
workshops and postgraduate courses. All proposals must
be submitted through the ATS Web site by June 30, 2011. To
submit a proposal, visit www.thoracic.org/go/call-for-input.
PRoPosed Amendments
to Ats BylAws
The ATS Board of Directors has approved a number
of amendments to the Society’s current bylaws. The
proposed amendments will be presented to members for
action at the 2011 ATS International Conference in Denver
during the annual Membership Meeting, which will be
held on Tuesday, May 17 at 11:30 a.m. in the Wells Fargo
Theatre of the Colorado Convention Center (section 2,
street level). To review the proposed changes, please
visit www.thoracic.org.
CliniCiAns CenteR
to offeR demonstRAtions
For the first time, the
Clinicians Center at
ATS 2011 will host live
product demonstrations
of medical devices. To
further enhance the
International Conference
experience for pulmonary,
critical care and sleep
medicine practitioners,
ATS experts will show the features of the devices and
how to use them in practice. Hands-on workshops on
therapeutic hypothermia and ultrasound techniques will
be presented at noon each day the center is open. Some
other highlights include:
• Clinical and Public Advisory Roundtable experts
will address an array of topics related to respiratory
diseases, critical illnesses and sleep disorders; and
• On Sunday, a reception will be held at 3 p.m. for
nurses, physical therapists, respiratory therapists,
physician assistants, clinical research coordinators and
other allied healthcare professionals.
The Center will be open from 7 a.m. to 4 p.m. from Sunday,
May 15, through Tuesday, May 17. A complimentary
breakfast will be served beginning at 7 a.m. and a social
hour featuring cocktails and hors d’oeuvres will be held
from 3 to 4 p.m. For more information, please visit
www.thoracic.org/go/clinicians-center.
ats news | vol.37 no.5 | may 2011 5

6
NEWS
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
SPOTLIGHT ON ATS COMMITTEES
International Conference Committee
marc moss, md, chair of the ATS International Conference Committee, talks about what he and his members are doing to improve the ATS International Conference
experience for attendees, whether they work in academia, private practice or industry.
Q. What is your committee’s charge?
A. The International Conference Committee is
responsible for planning, coordinating and implementing
the scientific and educational sessions, and other special
sessions of the ATS International Conference. This
responsibility includes securing, reviewing and selecting
papers for the scientific sessions, coordinating sessions
devoted to continuing medical education and supervising
the conduct and content of collaboratively sponsored
programs. Our committee evaluates the quality of each
year’s International Conference and proposes strategies to
improve the conference.
Q. Would you say your committee’s focus has
changed in the last several years?
A. We have been looking to identify novel methods to
improve the conference experience for the attendees. As
a result, it has become much more time consuming and
essentially a year-round job.
Q. In what ways has the International Conference
changed since you’ve been chair?
A. We have a very cohesive committee, and all of
our members deserve a lot of credit for the time and
effort they dedicate to planning the meeting. As a
group, we have initiated some new opportunities for
attendees, including the submission of case reports
and late-breaking abstracts. To improve scientific
interaction among investigators presenting their
original research at ATS 2010, we also increased the
number of facilitators at thematic poster sessions.
For the first time, there was one facilitator for every
eight to 10 posters at the International Conference.
In addition, faculty members were assigned to
specific posters, rather than just being assigned to a
large session with many posters. We also increased
the number of facilitators and decreased the number
of abstracts in each poster discussion session. Both
of these changes allowed facilitators the time to
© iStockPhoto
[ ]
JUST
APPROVED
&
lAUnchED
interact meaningfully with each presenter. Finally,
while it was difficult, we decreased the number
of abstract categories to facilitate the abstract
submission process.
Q. What do you see as areas that need improvement
over the next several years and what projects are in
the works?
A. The committee’s continuing goal is to work with
the members and other pulmonary experts to offer
a conference program that will address the needs of
our constituency. With the help and support of the
Society’s Education Committee, we will be instituting
a core curriculum for the International Conference
and all other ATS educational programs. This will be
a challenging initiative, but one that is vital for the
continued success of the meeting.
Q. As a pulmonologist and critical care specialist
who chairs the committee, what perspective do you
bring to the table?
A. I think I understand the balances that are required to
plan such a large meeting. The meeting needs to appeal
to a diverse group of individuals. Therefore, we must
balance the needs of clinicians and basic researchers;
pulmonary, critical care and sleep physicians; nurses and
other allied healthcare professionals.
Q. Is the make-up of your committee representative
of the Society’s membership at large or does it
represent a “subset” of ATS members?
A. With two elected representatives from each of the
ATS’s 13 assemblies and several at large positions, our
committee represents the Society’s diverse membership.
Q. Do you see many opportunities for collaboration
with other ATS committees?
A. Our committee has collaborated extensively with
many of the ATS committees. For example, we are
• Pharmaxis has announced the commercial launch of ARIDOL ® (mannitol inhalation
powder) Bronchial Challenge Test Kit, the first new bronchial challenge test in more
than two decades and the company’s first product launch in the U.S. ARIDOL is used
to assess bronchial hyperresponsiveness in patients six years of age and older who
do not have clinically apparent asthma. ARIDOL should not be used as a stand-alone
test to assess asthma or as a screening test for asthma, but as part of a physician’s
overall assessment of asthma. To learn more, please visit www.aridol.info.
The image on the left does not represent the product described in this column.
working with the Education Committee on
developing a core curriculum for the International
Conference. We are working with the Quality
Improvement Committee to initiate the programming
of quality improvement abstracts. We have worked
with the MITT committee to improve the experience
of fellows and junior professionals at the
International Conference.
meet tHe members oF tHe international
ConFerenCe Committee
marc moss, md (chair)
david H. au, md (vice-chair)
indu a. ayappa, phd
Jason H. t. bates, phd, dsc
margaret ann Carno, phd, mba, rn, Cpnp, Fnap
Francine Comi (staff)
Kristina a. Crothers, md
J. randall Curtis, md, mpH (ex-officio and non-voting member)
stephanie d. davis, md
robin r. deterding, md
niall d. Ferguson, md, msc
Kevin r. Flaherty, md
Christine m. garvey, Fnp, msn
Wanda m. gibson-scipio, phd, Fnp
susan H. guttentag, md
Carol dukes Hamilton, md
elizabeth o. Harrington, phd
nicholas s. Hill, md (non-voting member)
maritta s. Jaakkola, md
amy Jordan, phd
patricia a. Kritek, md
Francois maltais, md
greg s. martin, md, msc
bethany b. moore, phd
nicholas W. morrell, md
thomas m. murphy, md
irina petrache, md
Kristin a. riekert, phd
eileen rubin, Jd
marc b. schenker, md, mpH
dean e. schraufnagel, md (non-voting member)
beverley J. sheares, md, ms
peter J. sterk, md, phd
gregory tino, md
Carolyn H. Welsh, md
ats news | vol.37 no.5 | may 2011

AMERicAN thoRAcic SociEty
The ATS is pleased to
acknowledge its 2011
Corporate Members. image
Benefactor
Supporter
Friend
Thank you for your support.
For more information about the Corporate
Membership Program, please visit
www.thoracic.org.
© iStockPhoto

8
NEWS
Bernt Bogvald Aarli, MD
Bergen, Norway
Lucy Jane Abbott, MBBS, BSc(Hons),
MRCP(UK)
Farnham, Surrey, United Kingdom
Mohamad Shehata Abdelhafez, RT
Assiuit, Egypt
Vinu M Abraham, MBBS, MD, ABIM
Garland, TX
Tiziana Adage, PhD
Graz, Austria
Neill Adhikari, MD, FRCP(C)
Toronto, ON, Canada
Amit Adlakha, MBChB
London, United Kingdom
Tahira Zareen Adnan, MBBS, Dip
Slough, South Bucks, United Kingdom
Tauseef Afaq, MD
Columbus, OH
Punit Agarwal, MBBS, BMedSci,
MRCP(UK)
Chelmsford, Essex, United Kingdom
Zubin Agarwal, BA(Hons), MPH
Rochester, MN
Cara Agerstrand, MD
New York, NY
Saurabh Aggarwal
Augusta, GA
Tanupriya Agrawal, MBBS
Omaha, NE
Farida Ahangari, MD
Branford, CT
Shawn Kristopher Ahlfeld, MD
Indianapolis, IN
Wasim Ahmed, MBBS
Karachi, Sindh, Pakistan
Anup Ahmed, MBBS
Malappuram, Kerala, India
Jaspreet Ahuja
New York, NY
Bardia Akbari, PharmD
Nutley, NJ
Shamsuddin Akhtar, MBBS
Middlefield, CT
Kamal Akhtar, PhD
St. Louis, MO
Mohammed Dhafer Al Ahmari, RRT
Khobar, Saudi Arabia
Mohammed Al Faiyumi, MBBS
Royal Oak, MI
Mukhallad M Al Janabi, PhD
Irbid, Jordan
Mazen Al-Alawi, MD
Dublin, Ireland
Mohammed Ahmad Al-Hijji, MD
Doha, Qatar
Turki Saad Alahmadi, MBBS
Montreal, QC, Canada
Zouheir Jamil Alameh
ALEY, Lebanon
Tyler J. Albert, MD
Seattle, WA
Rino Aldrighetti
Silver Spring, MD
Melannie Alexander, BS
Columbia, SC
Diana Mihai Alexandru, DO, MD
Portland, Maine
Ahmad Alhajhusain, MD
Morgantown, WV
Mouhsen Alhakeem, ABIM, MD
Royal Oak, MI
faris falah alhejaili, MB
London, ON, Canada
Tarig Ali-Dinar, MD
Miami, FL
Salman A. Aljubran, MD
Tampa, FL
Eyad Almasri, MD
Fresno, CA
Saleh Abdulrahman Alnasser, MD
Montreal, Quebec, Canada
Hilal Altinoz, MD
Istanbul, Turkey
Mehmet Altunisik
Malatya, Turkey
Chandana P. Amerasinghe, MD
Colombo , Sri Lanka
Nasim Amirjani, MD, PhD
Randwick, Syndey, Australia
Shirish Amrutia, MD
Cherry Hill, NJ
Alfred Onubia Andama, CLS
Kampala, Uganda
Leslie Baitinger Andersen, MT(ASCP),
BMT, MS
Chapel Hill, NC
John Taylor Anderson, ABIM
Mount Olive, AL
Annika Andersson Sjaland, PhD
Lund, Sweden
William Ross Andrews, MD, MS
Advance, NC
Phyllis R. Angelico, AA, RRT
Carlsbad, CA
Crystal Anglen, PhD
Foster City, CA
Ahmad Tariq Ansari, MBBS, PCP
Al Ain, United Arab Emirates
Bilal Ansari, BM BCH
Galway, Ireland
Balazs Antus, MD
Budapest, Hungary
Yoshinori Aono, MD, PhD
Durham, NC
Naoki Arai
Tokyo, Japan
Juan Carlos Arango, MD
Medellin, Antioquia, Colombia
Jairo Sponholz Araujo
Curitiba, PR, Brazil
Santiago Cruz Arce, MD
Buenos Aires, Argentina
William Arciniegas, MD
Bogota, Colombia
Oana Cristina Arghir, ACNS-BC, CMS,
MD, RRT, RT
Constanta, Constanta, Romania
Ahmed Arif, PhD
Charlotte, NC
Syafri Kamsul Arif, MD
Makassar, South Sulawesi, Indonesia
Ricardo Aristizabal, MD
Bogota, Colombia
Daniel Arizpe-bravo
Puebla, Puebla, Mexico
Teresa Arledge, DVM
Raleigh, NC
Begum Ergan Arsava, MD
Ankara, Turkey
Antje Jeanette Ask, MD
Ancaster, ON, Canada
Kazuaki Atagi, MD
Kyoto, Japan
Robert S Aucker, PharmD
Brentwood, TN
Gade Avinash, MBBS
Hyderabad, India
Samah Mashhour Awad, MBBS
Little Rock, AR
Metin Aytekin, AAS, PhD
Cleveland, OH
Meghan Azad, PhD, BSc(Hons)
Winnipeg, MB, Canada
Renato de Lima Azambuja, MD
Rio de Janeiro, RJ, Brazil
Motoo Baba
Tomigusuku, Japan
Abraham Samuel Babu, PT
Manipal, Karnataka, India
Reem Majed Badarneh, BSc(Hons)
Haifa, Israel
Sridhar Badireddi, MBBS, ABIM
Little Rock, AR
Marie Baekvad-Hansen, MSc
Herlev, Denmark
Shakeel A Bahadur, MD
Massillon, OH
Rachel L Bailey, DO, MPH
Morgantown, WV
Edward Baker
South San Francsico, CA
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
ATS WelcomeS NeW memberS The Society welcomes the
Jessie P Bakker, PhD
Boston, MA
Cecile Balagtas, PhD
New York, NY
Gayathrly Balamayooran, DVM
Baton Rouge, LA
Milind Baldi, MD, MBBS
Indore, MP, India
Guillermo Jose Ballarino, MD
Washington, DC
Alison Bamberg, BS
Denver, CO
Vijay Bandhakavi, MD
New Berlin, WI
Debabrata Bandyopadhyay, MBBS,
MD, MRCP(UK)
Shaker Heights, OH
Eva Baroke, MD
Hamilton, Ontario, Canada
Eliane Roseli Barreira, MD
Sao Paulo, Brazil
Carlos Alberto Barrero, MD
Philadelphia, PA
Tara L. Barto, MD
Charleston, SC
Gregory Ashton Bassmann, MD
Baltimore, MD
Rajit K. Basu, MD
Cincinnati, OH
Sanjay Batra, MD
Baton Rouge, LA
Philip Bauer, PhD
Pittsburgh, PA
Eileen Bauer, PhD
Pittsburgh, PA
Carla Maria Teresa Bauer, BM
Hamilton, ON, Canada
Paul Bauer, MD
Milwaukee, WI
Rebecca Bauer
Chapel Hill, NC
Brian Bauman, MD
Akron, OH
Mehmet Bayram, MD
Sivas, Turkey
Michele Anne Bazinet-Bossert, RN
Plymouth, MN
Celine Ann Beamer Shepherd, PhD
Missoula, MT
Kyle Beauchemin
Lamoine, ME
Stacey Beckhardt
Frazer, PA
Stephen Beckman, MBA
Exton, PA
Abbie Begnaud, MD
Gainesville, FL
Tatsiana Y. Beiko, MD
Galloway, NJ
F Javier Belda, MD, PhD
Valencia, Spain
Maria Guacolda Benavides, MD
Santiago, RM, Chile
Glenda Nicole Bendiak, FRCP(C), MD
Toronto, ON, Canada
Blake Bennett, BS
Baltimore, MD
Christina K. Benninger, BSN, RN
Louisville, KY
Dan Benscoter, DO
Cincinnati, OH
Marieke Berger, MS
Amsterdam, Netherlands
Philip John Berger, PhD
Clayton, Victoria, Australia
Annerose Berndt, DVM, PhD
Pittsburgh, PA
Gillina Bezemer, BMedBiol, MSc
Utrecht, TB, Netherlands
Ravinder Datt Bhanot, MBBS
Ludhiana, Punjab, India
Rahul Bhat, BM BCH, MRCP(UK)
Stoke-on-Trent, United Kingdom
Swati A. Bhatawadekar, MA, MSc
Halifax, NS, Canada
Amrithraj Bhatt, MBBS, MRCP(UK)
Pontyclun - Mid Glamorgan, United
Kingdom
Paramveer Bhugra, MD
East Providence, RI
Charlotte Katherine Billington,
BSc(Hons), PhD
Nottingham, United Kingdom
Amsalu Bekele Binegdie, MD
Addis Ababa, Ethiopia
Shiva Birdi, MD
Westfield, OH
Debabani Biswas, MD
Kolkata, WB, India
Katharine E. Black, MD
Cambridge, MA
Charles Bradford Black
Libby, MT
Jennifer L Black-Shinn, CRT, RPSGT,
MPH
Parker, CO
Kathryn Blake, PharmD
Jacksonville, FL
Alan Blau, PhD
Fairfield, CT
Joan Przybocki Blonder, PhD
Boulder, CO
Brian Bloom, MD, MBA
Quincy, MA
Lucas Boeck
Basel, Switzerland
Jessica Boehmler, MD
Baltimore, MD
Bart Boerrigter, MD
Amsterdam, Netherlands
Alexander Bohla, MS
Neuhrenberg, Germany
Catherine Bonham, MD
Ypsilanti, MI
Frank Bonsu, MD, MPH
Accra, Ghana
Gladys Bonsu, BScN
Tema, G-Accra, Ghana
Viboon Boonsarngsuk
Bangkok, Thailand
Lieuwe Durk Jacobus Bos, BM
Amsterdam, Netherlands
Samrat Bose, MBBS, MRCP(UK)
Harrow, United Kingdom
Miguel Botero
Bogota, Colombia
Gabriela Irina Botez, MD
Cincinnati, OH
Timothy Hunter Bouck, MD
Rochester, NY
Emilie Bourdonnay, PhD
Ann Arbor, MI
Jane Elizabeth Bourke, BS(Hons), PhD
Parkville, Victoria, Australia
Paul Douglas Bozyk, MD
Ann Arbor, MI
Wesley A Braden, PhD
Chicago, IL
Darragh Brady
New Haven, CT
Charles Bramlage, MBA
Redwood City, CA
Johann C Brandes, MD, PhD
Atlanta, GA
Cynthia Ann Brewer, BS
Roseville, CA
Eric Brideau
Dieppe, NB, Canada
Katrien Marleen Brouwer, MSc
Nijmegen, Netherlands
Michael Davidson Brown, MD
Birmingham, AL
Shannon Bruse, PhD
Albuquerque, NM
Tracey Bryan, MD
Edmonton, AB, Canada
Dragos Bumbacea, OTR
Bucharest, Romania
Patrick Burkett, MD, PhD
Boston, MA
Nicole Theresa Burton, BSc
Providence, RI
Santiago Cadena, MD
Quito, Ecuador
Juan Carlos Calderon
Guayaquil, Guayas, Ecuador
Rafael A. Calderon Candelario
San Juan, Puerto Rico
Alejandra Canas
Bogota, Distrito Capital, Colombia
Thuc Xuan Cao, MS
Ho Chi Minh City, Vietnam
Brian B. Carlson, PhD
Fullerton, CA
Jacob Jonas Carmichael, MD, BS
San Francisco, CA
Eva Maria Carmona Porquera, MD,
PhD
Rochester, MN
Tomás Patrick Carroll, BSc(Hons),
MSc, PhD
Dublin, Leinster, Ireland
Michael Sean Carroll, PhD
Chicago, IL
Jacqueline Carsanaro, MBA
Research Triangle Park, NC
Laura De Siqueira Castro, MD
Sao Paulo, Brazil
Katherine Therese Cayetano Cayetano,
DrMed
Sacramento, CA
Ching Li Chai-Coetzer, MBBS
Adelaide, South Australia, Australia
Elizabeth Anne Champion, MPH, MD
Chapel Hill, NC
Melina Chan, MD
Little Rock, AR
Mario Luis Chancay
Quito, Pichincha, Ecuador
Anil Kumar Changarath Vijayan, MD
Chicago, IL
Emily Charlson, BS(Hons)
Philadelphia, PA
Christine Charman, BPharm
Horsham, West Sussex, United
Kingdom
Jonathan E .Charnin, MD
Boston, MA
Sushil Chaturvedi, MD
Luckwow, UP, India
Jonathan Cheetham, DVM, PhD
Ithaca, NY
Jiwang Chen, PhD
Chicago, IL
Zhihong Chen, MD, PhD
Shanghai, China
Igor Chernyaev, MD
Yekateringburg, Russian Federation
Naomi C. Chesler, PhD
Madison, WI
Noemie Chessex, MD
Thunder Bay, ON, Canada
Sunil K. Chhabra, MD
Delhi, India
Mark A. Chilvers, BSc(Hons), MD,
MBChB
Vancouver, BC, Canada
Livingstone Chishimba, MRCP(UK),
BM BCH, BScM
Manchester, United Kingdom
David McAvoy Chooljian, MD, JD
Stanford, CA
Will Chou, MD
South San Francisco, CA
Ara Chrissian, MD
West Hills, CA
Stephanie Christenson, MD
San Francisco, CA
Piyaporn Chuen-im, MD
St. Louis, MO
Christopher Michael Cielo, DO
Philadelphia, PA
Brian Civic, MD
Philadelphia, PA
Margaret Bradley Clarke, MD
Sioux Falls, SD
Christopher Clevenger, PhD
South San Francisco, CA
Jonathan Marc Cohen, BM BCH, PhD,
MSc, MA
London, United Kingdom
Charlotte W. Collins, JD
Landover, MD
Brian S. Comer, AA, BS
Mobile, AL
Chris Compton, MBChB
Horsham, West Sussex, United
Kingdom
Helcio M. Conde, MD
Rio De Janeiro, Brazil
Robin Anthony Condliffe, MD
Sheffield, United Kingdom
Geoffrey Robert Connors, MD
Baltimore, MD
Galo Fernando Constante
Cumbaya, Pichincha, Ecuador
Maya Contreras, MD
Galway, Ireland
William Francis Conway, MD
Savannah, Tennessee
Cinzia Cordazzo, BSc
Pisa, Italy
Tamera Jo Corte, MD, PhD
Sydney, Australia
Gina Coscia, MD, BSc
New York, NY
Claudia Henrique Costa, BScM, MD,
PhD
Rio de Janeiro, Brazil
Ian P. Counihan, MB
Dublin, Ireland
Audrey Courboulin, MSc
Quebec, Canada
Sonya E. Craig, BA(Hons), MBChB,
MRCP(UK)
Wallingford, Oxfordshire, United
Kingdom
Patrick “Jake” Cripe, MD
Denver, CO
Michael T. Crow
Baltimore, MD
Matthew Crull, MD
San Diego, CA
Carissa Marie Cruz, ABIM
San Juan, Puerto Rico
Elizabeth Cullen, MSN
Worcester, MA
Kristin J. Cummings, MD, MPH
Morgantown, WV
Tara Curtis-Haberlock, PA-C
Bismarck, ND
Jaime M. Cyphert, BS, PhD
Research Triangle Park, NC
Christopher Albert Czaja, MD, MPH
Denver, CO
Katarzyna Czarnecka-Kujawa, MD,
BS(Hons)
Oakville, ON, Canada
Eli Joseph Dabscheck, MBBS
Melbourne, VIC, Australia
Shyamala Dakshinamurti, MD
Winnipeg, MB, Canada
Chris Phillip Daley, MBBS
Bentleigh East, Victoria, Australia
Triya Damayanti, MD
Sendai, Miyagi, Japan
Hemant Pratap Dand, MD
Dallas, TX
Ninh Dang, MS
Danang, Vietnam
Mary Leigh Anne Daniels, MD, MPH,
BA
Chapel Hill, NC
Tran Thi Hong Dao, BP
Ho Chinh Minh, Vietnam
Aparna Das, MBBS
Chevy Chase, MD
Shailendra Das, DO
Houston, TX
Wilzinir .F Das Neves, PCP
Sao Paulo, Brazil
Vrushank Dave, MS, PhD
Tampa, FL
(continued on page 9)
ats news | vol.37 no.5 | may 2011

NEWS
Eric John David
Miraj, Maharashtra, India
Bruce Alan Davidson, PhD
Buffalo, NY
Stephen Dawe, BSc(Hons)
Horsham, West Sussex, United
Kingdom
Mark De Caestecker, PhD
Nashville, TN
Leandro Antonio De Castilho
Sao Paulo, Brazil
Jantina Christina de Groot
Groningen, Netherlands
Sonia Rocio De Janon Quevedo, MD
Guayaquil, Guayas, Ecuador
Frances De Man, PhD
Amsterdam, GB, Netherlands
Andres De Vivero
Bogota, Colombia
Shampa De-Oertel, PhD, BS
Los Angeles, CA
Naomi Louise Deacon, BSc(Hons)
Adelaide, SA, Australia
Tomasz Dabowski, MD, PhD
Warsaw, Poland
William E. Del Poso, MD
Quezon City, Philippines
George Dela Cerda, PharmD, RPh
Chicago, IL
Diana Deleanu, RRT
Cluj Napoca, Romania
Linhong Deng, PhD, MSc, BSc
Shapingba, Chongqing, China
Christi Denton, BS, BSN, FNP
Chattanooga, TN
Ronald James DePue, PharmD
Richmond, VA
Philip Alexander Derchak, PhD, MS
Foster City, CA
Tapan Apurva Desai, ABIM
Scottsdale, AZ
Vikrant Suresh Deshmukh, MD
Nagpur, Maharastra, India
Chris DeWilde
Richmond, VA
Ramandeep Dhaliwal, MBBS
Omaha, NE
Ruvini Thushara Dharmagunawardena,
MBBS
London, United Kingdom
Amit Dhingra, MD
Knoxville, TN
Allan Dias, MD
Boston, MA
Nguyen Thi Ho Diep
Ho Chi Minh City, Vietnam
Genevieve Christina Digby, MD
Kingston, ON, Canada
Emily DiMango, MD
New York, NY
Amy DiMarino, DO
Cleveland, OH
Georgios Stamatios Dionellis
Athens, Neos Kosmos, Greece
Richard A.F. Dixon, PhD
Houston, TX
Pascal Djiadeu
Toronto, ON, Canada
Venkata Dodda, MBBS, MD
Bronx, NY
Puttappa Dodmane, BVSc, MSc
Omaha, NE
Lisa M. Dominak, PhD
Cleveland, OH
Gavin Christopher Donaldson, PhD,
BSc(Hons)
London, United Kingdom
Viliam Donic, MD, PhD
Kosice, Slovakia
Graham M. Donovan, PhD
Auckland, New Zealand
Kelly Dooley, MD, PhD
Baltimore, MD
Jonne Doorduin, BSc, MSc
Nijmegen, Netherlands
Alejandro Dorenbaum, MD
South San Francisco, CA
David Nobuhiro Douda, MSc
Toronto, ON, Canada
Jennifer I Drake, BS, MS
Richmond, VA
Kylie M. Drake, BS(Hons), PhD
Cleveland, OH
Barbara Driscoll, PhD
Los Angeles, CA
Lee Reinhold Droemer, MD
Nashville, TN
Michael Durheim, MD
Durham, NC
Mladen Duronjic, MD
Banja Luka, Bosnia and Herzegovina
Debbie Durrer
Chicago, IL
Neil Duval, MD
Lewiston, ME
Andres Luis Echazarreta
La Plata, Buenos Aires, Argentina
Sandrah P Eckel, PhD
Los Angeles, CA
Roger A. Edwards
Boxborough, MA
Monica Maria Egozcue-Dionisi, MD
Guaynabo, Puerto Rico
Ahmed Hesham El-Hashash, PhD
Los Angeles, California
Omer Elganbi Yousif Elhag, MD
Khartoum, Sudan
Arnon Elizur, MD
Beer Yaakov, Israel
Kristin Marie Elliott, MSN, ACNPC
Algonac, Michigan
Mai Kamal ElMallah
Gainesville, FL
Wael ElMaraachli, MD
San Diego, CA
Asma Ismael Elsony, MD
Khartoum, Sudan
Osman Eltayeb, MPH
Ibadan, Oyo, Nigeria
Paul Engels, MD
Toronto, ON, Canada
Anthony Enimil, MD
Kumasi, Ashanti, Ghana
Oleg Epelbaum, MD
New York, NY
Mukremin Er, MD
Ankara, Turkey
Shiv Kumar Erigadoo, MBBS
Brisbane, QLD, Australia
Ki-Do Eum, PhD, MPH
Boston, MA
Robin Smith Everhart, PhD
Providence, Rhode Island
Fatma Evyapan, PhD, MD
Denizli, Turkey
Domenick Fanelli, PhD, MBA
Research Triangle Park, NC
Claude S Farah, MBBS
Five Dock, NSW, Australia
David George Stephen Farmer,
BSc(Hons)
Glasgow, United Kingdom
Emily Farrell, PhD
Madison, WI
Siavash Farshidpanah, MD
Rancho Cucamonga, CA
Jeffrey Feinstein, MD, MPH
Palo Alto, CA
Bryce Ferguson, MD
Cincinnati, OH
Lalita Fernandes, MD
Caranzalem, GOA, India
Juan Felipe Fernandez, MD
San Antonio, TX
Isis E Fernandez, MD
Boston, MA
Bruno Leonel Ferreyro
Buenos Aires, Capital Federal,
Argentina
Eric C Feucht
Kalamazoo, MI
ats news | vol.37 no.5 | may 2011
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
following domestic and international members who joined the ats between January 1, 2011 and march 31, 2011.
(continued from page 8)
Glen Firestone
North Wales, PA
Rafael Firszt, ABP
Durham, NC
Carl Flatley
Dunedin, FL
Carlos Enrique Flores, CIC, DCH, MD
Santiago, Chile
Jorge Florindez, MD
Bridgeport, CT
Robert S. Fontana, MD
Rochester, MN
Rebecca Louise Forbes, BSc(Hons),
BSc
New Lambton, NSW, Australia
Jennifer Ruth Foster, BS(Hons), MD
London, ON, Canada
Nathaniel Fox
Monroeville, PA
Kelly Lynn Fox, RN, BSN
Hendersonville, TN
Yuji Fujikura, MD
Tokorozawa, Japan
Asako Fukuyama, MD
Uruma, Okinawa, Japan
Kate Hannah Gaffey, BSc, MSc
Lancashire, United Kingdom
Wenqi Gan, MD
Vancouver, British Columbia, Canada
Simon C Gandevia, DSc, MD, PhD
Randwick, Sydney, NSW, Australia
Neel R. Gandhi, MD
New York, NY
Guillermo Montes Garcia
Morelia, Michoacan, Mexico
Roxanne Garcia Orr
Glendale, AZ
Garth Garrison, MD
Ann Arbor, MI
Grzegorz Gaszczyk
Karpacz, Poland
Bill Gaussa, MBA
Monroeville, PA
Qi Ge, BSc
Sydney, Australia
Elizabeth Gendy-Shaker, MD
Anaheim, CA
Julian J. Genis Zarate, MD
Nuevo Laredo Tamps, Mexico
Norma P Gerard, PhD
Boston, MA
William Gerhart, MBA
San Diego, CA
Yael Gernez, MD, MSc
Palo Alto, CA
Jennifer S. Gewandter, MS
Rochester, NY
Saad Ghafoor
St. Louis, MO
Shaista Ghazal, BM BCH
Karachi, Sindh, Pakistan
Eugene Gibbs-Flournoy, MS, BS
Chapel Hill, NC
Rima Gidwani, MD
Dallas, TX
Amanda LA Giesler, BSc(Hons)
Hamilton, ON, Canada
Christopher Gilbert, DO, BS
Philadelphia, PA
Sandra K. Gilley, MD
Birmingham, AL
Andrew Gillman, BM
Donvale, VIC, Australia
Paresh Chandra Giri, MD
Redlands, CA
Leonard Gitter, MD
Brooklyn, NY
Bjarte Gjerde, MD
Bergen, Norway
Thomas Glaab, MD
Ingelheim, Germany
Louisa Glackin, MBChB
Dublin, Ireland
Pieter Christian Goeminne, MD
Leuven, Vlaams-Brabant, Belgium
John Francis Golder, BVSc, PhD
Horsham, PA
Monica Prasad Goldklang, MD
New York, NY
John Clifford Gomez, PhD
Chapel Hill, NC
Jose Gomez-Arroyo
Mexico City, Mexico
Huan Gong, DSc
New Haven, CT
Paramjyothi Kruparao Gongati, MBBS,
MBChB
Hyderabad, Andhra Pradesh, India
Thomas Goodin, PhD
Jersey City, NJ
Gokul Gopalan, MD, MPH
Kenilworth, NJ
Umesh Goswami, MD
Minneapolis, MN
Michael S. Gough, MD
Kenmore, NY
Christine M. Gould, MD
Washington DC, MD
Catherine Jane Gowland, BSc(Hons)
Nottingham, United Kingdom
Timur Tafari Graham, MD
Providence, RI
Edward Grandi
Washington, DC
Mary Jo Grant, PhD, PNP-BC
Salt Lake City, UT
Melonie Grant, RN
North Wales, PA
Kent Green, MD
Kongens Lyngby, Denmark
Catherine Greene, BA, PhD
Dublin, Ireland
Courtney Christine Greene, DrMed
Seattle, WA
Neal S. Greenfield, MD, ABIM
Chicago, IL
Travis Greer, MD
Charleston, SC
Katie Grinnell, PhD
Providence, RI
Martijn Robert Groenendijk
Amsterdam, Netherlands
Herman Groepenhoff, MSc
Amsterdam, Netherlands
Luca Gronchi, PA
Casciana Terme, Pisa, Italy
Christine Marie Gross, BS
Augusta, GA
Dion Craig Grosser, FRACP, MBBS
Healthfield, SA, Australia
David Grove, PhD
Cleveland, OH
Gabriele Grunig, DVM, PhD
Syosset, NY
Heather Guerrero
Foster City, CA
Maria Guglielmo, MD
Avellane da, BS AS, Argentina
Arun Maiya Gundmi, PT, PhD
Manipal, Karnataka, India
Tom Guntly, BS
San Francisco, CA
Rakesh Chandra Gupta, MBBS, MD
Ajmer, Rajasthan, India
Markus Gutsche, MD
Menlo Park, California
Maria Claude Guzman, MD
Bogota, Colombia
Jonathan Hacha, MS
Sart-Tilman, Belgium
Tillie-Louise Hackett, PhD, BS(Hons)
Vancouver, BC, Canada
Hans Michael Haitchi, MD, PhD
Southampton, Hampshire, United
Kingdom
Michael Scott Halbreiner, MD, BSc
Huntington, NY
William B. Hall, MD
Durham, NC
Hiroshi Hamakawa, ChD
Kobe, Hyogo, Japan
Parviz Hamedani, MD
Winston Salem, NC
Abdul G. Hameed, BM, BSc(Hons)
Sheffield, South Yorkshire, United
Kingdom
Mansoor Hameed, MRCP(UK), MBBS
Exeter, United Kingdom
Harsha Vardhan Hampasandra Madan
Kumar, MD
Chicago, IL
Shigeo Hanada, DPM
Minato-ku, Japan
Liam Michael Hannan, MBBS
Abbotsford, Victoria, Australia
Jessica Hansen, BS
Sleepy Hollow, NY
Nii Nortey Hanson-Nortey, MBChB,
MPH
Accra, Ghana
Yannis Hara
Paris, France
Michelle Hardyman, BSc(Hons)
Southampton, United Kingdom
Paul Harris, BSc(Hons)
Nutley, NJ
Joanna Hart, MD
Philadelphia, PA
Seth D. Hartung, MD, PhD
Seattle, WA
Nur-Shirin Harun, MBBS
Melbourne, Australia
Naveed Hasan, MBBS
Syracuse, NY
Nadia A. Hasaneen, MD
Smithtown, NY
Jeffrey A Haspel, MD
Brookline, MA
Luke Michael Hatchwell, BMedBio
Newcastle, NSW, Australia
Brie Hawley, MS
Fort Collins, CO
Chao He, Bmed
Iowa City, IA
Jason Heavner, MD
Hamden, CT
Rebecca L. Heise, PhD
Fredericksburg, VA
Michelle Hernandez, MD
Durham, NC
Susanne Herold, MD
Giessen, Germany
F. William Hersman, PhD
Durham, NH
Mohammadreza Heydarian, PhD
London, ON, Canada
David Hiestand, MD
Louisville, KY
Linda Slanec Higgins, PhD
Foster City, CA
Jacques Hilton Waisman
Recife, Brazil
Melissa J. Hinton, MSN
St. George, UT
Matsunaga Hiroya, BS
Kitakyushu, Fukuoka, Japan
Laura Lam Hoang, BS
Davis, CA
Sandra Hoegl, MD, DrMed
Munich, Germany
Neil S. Holden, BSc, PhD
Calgary, AB, Canada
Trina J Hollatz, MD
Madison, WI
Kristen Holm, PhD, MPH
Denver, CO
Stephanie Hon, BA
Burlington, MA
Nicholas S Hopkinson, MRCP(UK)
London, United Kingdom
Yasushi Horimasu, MD
Hiroshima, Japan
Craig Horvat, MD
Lancaster, PA
Karin Hoth, PhD
Denver, CO
Marie-Andrae Houle, MD
Sherbrooke, QC, Canada
Grace Harrington Houser, MD
Birmingham, AL
Andre Dresler Hovnanian, MD
Sao Paulo, Brazil
Joshua Hozella, BS
Hershey, PA
Chung-Hsing Hsieh, MD
New Taipei City, Taiwan
Jian Lin Hu, MD
Chong Qing, China
Joseph Huang, MD
New York, NY
Kun-Lun Huang, MD, PhD
Taipei City, Taiwan
Delphine Janmei Huang, BA
San Francisco, CA
Christopher Hug, MD, PhD
Boston, MA
J. Margaret Hughes, BS(Hons), PhD
Sydney, Australia
Kendall Stephen Hunter, PhD, MS, BSc
Aurora, CO
Jessica Rae Hurley, BS, DO
Glendale, AZ
Tuan Anh Huynh, MS
Can Tho, Vietnam
Harold Humberto Ibagon
Bogota, Colombia
Omar Ibrahim, MD, BA
Philadelphia, PA
Yasunori Ichimura, MD
Chiba-shi, Chiba, Japan
Svetlana Ilina, ACNS-BC
Moscow, Russian Federation
Jacqueline Kay Imm, BA
Hillsborough, NC
Takashi Inomata, MD
Sapporo Hokkaido, Japan
Minoru Inomata, DrMed
Shibuya-ku, Tokyo, Japan
Ruxandra Corina Ionescu, MD
Indianapolis, IN
Ramona Nicoleta Ionita, MD
Oak Park, IL
Marleine Ishak, DrMed
New Haven, CT
Haruyuki Ishii, MD, PhD
Mitaka city, Tokyo, Japan
Tosihiro Isii, GP
Yuhu, Japan
Heba Ismail, MBChB
Sacramento, CA
Kensho Iwanaga, MD
Seattle, WA
Vivek N. Iyer
Rochester, MN
Krishna S. Iyer, BSc
Iowa City, IA
Matthieu Jabaudon
Clermont-Ferrand, France
Benedicte Jacquemin, MD, PhD
Villejuif, France
Yoneth Alexandra Jaimes Cristancho,
MD
Bogota, Colombia
Patricia Jamerson, PhD, RN
Saint Peters, MO
Nira Janbur
Chambersburg, PA
Barbara Jandasek, PhD
Providence, RI
Mary Janevic, PhD, MPH
Ann Arbor, MI
Robert Jaramillo, PharmD, PD
Salt Lake City, UT
Melanie J. Jardim, PhD
Chapel Hill, NC
Jen-erh (David) Jaw, MSc, BSc
Vancouver, BC, Canada
Eric I-Hun Jeng, MBA, MD
Chicago, IL
Phillip Jennings, PharmD
Knoxville, TN
Yun Jeong Jeong, MD
Seoul, Korea, Republic of
(continued on page 10)
9

(continued from page 10)
Leslie Jette, BS, MS, MD
Dupont, WA
ByungWoo Jhun, BScM
Seoul, Korea, Republic of
Arnel Gerald Jiao, MD
Quezon City, Philippines
Quirijn Jabsis, MD, PhD
Maastricht, Netherlands
Kerri Ann Maria Johannson, MD
Calgary, AB, Canada
Sinoj John, MD
West Lebanon, NH
Bryon Nicholas Johnson, ABIM, DO
Coralville, IA
James C Johnston, FRCPC, MD
Boston
Elizabeth Joseph, MPH
Ridgefield, CT
Avni Y. Joshi, MD
Rochester, MN
Mark W. Julian
Columbus, OH
Madhulika Jupelli, MS
San Antonio, TX
Nelson Kalema, MBChB
Kampala, Uganda
Sunil Kamath, MD
Walnut, CA
Pitchaimani Kandasamy, PhD
Denver, CO
Hyo Jae Kang, MD
Seoul, Korea, Republic of
Kirsten Neudoerffer Kangelaris, MD
San Francisco, CA
Vanina Siham Kanoore, MD
Capital Federal, Buenos Aires,
Argentina
Samantha Kantrowitz
Seattle, WA
Lata Kaphalia, PhD
Galveston, TX
Akshat Kapur, MBBS, MRCP(UK)
Glasgow, West Dunbartonshire, United
Kingdom
Volkan Kara, MD, PhD
Istanbul, Umraniye, Turkey
Harry Karmouty Quintana, BSc(Hons),
PhD
Houston, TX
Razul Nazri Kassim, MD
Nibong Tebal, Penang, Malaysia
Lynn Katz, RPh, PharmD
Akron, OH
Hidenori Kawakami, MD
Niigata, Japan
Shigeo Kawase, MD
Hiroshima, Japan
Jennifer Kaya, MD
Honolulu, HI
John Kazianis, MD
New York, NY
Nisarfathima Kazimuddin, MD
Bowling Green, Kentucky
Syed Murtaza Hassan Kazmi,
MRCP(UK), MBBS
Warrington, United Kingdom
Kallirroi Kefala, MBChB, MRCP(UK),
MD
Toronto, ON, Canada
Emer Kelly, MD
Jamaica Plain, MA
Margaret Mary Kelly, MBChB, PhD
Calgary, AB, Canada
Fiona Kermeen, MBBS
Brisbane, QLD, Australia
Jessica Anne Kermode, BSc(Hons)
Coogee, NSW, Australia
Sophie Jane Kerr, MBChB, MRCP(UK)
Dublin, Ireland
Colleen Keyes, MD, MPH
Boston, MA
Misbahuddin Khaja, MD
Monsey, NY
Ihsan U. Khan, MD
Brooklyn, NY
10
NEWS
Nadir Kharma, BSc, MD
Winnipeg, MB, Canada
Said Younes Khatib, PhD
Irbid, Jordan
Aamir Madatali Khoja
Pune, Maharashtra, India
Talat Kilic
Malatya, Turkey
Paul Kim, ABP, MD
Los Angeles, CA
Yan Kim, MD
Los Angeles, CA
Elson Kim, PharmD
Folsom, CA
Seo Yun Kim, MD
Seoul, Korea, Republic of
Eun Kyung Kim, Bmed
San Francisco, CA
Yosuke Kimura, MD
Niigata, Japan
Bryan King, MS, MD
Irvine, CA
Gregory Kinney
Aurora, CO
Denay P. Kirkpatrick, MSN
Birmingham, AL
Goksel Kiter, MD
Denizli, Turkey
Natalie Kitterman
Salt Lake City, UT
Abhilash Srikumar Kizhakke Puliyakote,
MS
Iowa City, IA
Emile Klada, MD
Brooklyn, NY
Walter Klein, MD
Grand Terrace, CA
Paul Kleinow, MD
Detroit, MI
Etai Kloog, PhD
Boston, MA
Dylan Girard Kluck, BA
Boulder, CO
Melissa P Knauert, PhD, MD
Milford, CT
Matthew Fitzgerald Knoch, MD
Cleveland Heights, OH
Lars Knudsen, MD
Hannover, Germany
Alexey Knyazhitskiy, MD
Burlington, VT
Katrin Kohse, MSc
Neuhrenberg, Bayern, Germany
Takeshi Koizumi, MD
Niigata, Japan
anand kommuri, MBBS, MD,
MRCP(UK)
Bryn Mawr, PA
Sophia Konstantinopoulou
Philadelphia, PA
Hyeon-Kyoung Koo, MD
Seoul, Korea, Republic Of
Karen Kin-Yue Koo, MD, FRCP(C)
London, ON, Canada
Felix Kork, MD
Berlin, Germany
Kalyan Kosuri, MD
Troy, MI
Sainath R. Kotha, MD
Columbus, Ohio
Melissa Ann Kovach
Ann Arbor, MI
Adrienne Kovalsky, DO, MPH
Chicago, IL
Violet Kramer, MD
Tinton Falls, NJ
francine krause, CRT, AAS, BA
Manchester, NJ
Olga Kravchuk, BA
Iowa City, IA
Nina S. Krimshtein, MD
New York, NY
Martijn Kross
Haarlem RJ, Netherlands
Richard F. Kucera, MD
Greensburg, PA
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
ats WelComes neW members the society welcomes the
Frank K. Kuhr, PhD
Chicago, IL
David Kung, ABIM, MD
New York, NY
Chioma Nneka Kunle-Ope, MSc
Yaba, Nigeria
Dhananjay Praghakar Kunte, PhD
Vernon Hills, Illinois
Oren Kupfer, MD
Aurora, CO
Paulo Cesar Kussek, MD
Curitiba, Parana, Brazil
Marrah E. Lachowicz-Scroggins, PhD
Rocklin, CA
Amruta Lacy-Colson, MBBS,
BSc(Hons), MRCP(UK)
Walsall, West Midlands, United
Kingdom
Lies LaHousse, PharmD
Gent, Belgium
Ying Lai
Seattle, WA
Preeti Lal, PhD
Santa Clara, CA
Jonathan Lam, PhD
Bethesda, MD
Matthew D. Landrigan, PhD
Warsaw, IN
Charles Randall Lane
Cleveland Heights, OH
Amber S. Lanich, ACNPC
Fort Thomas, KY
Kiranmayee Lanka, MD, MPH
Toledo, Ohio
David John Lapinsky, PhD
Pittsburgh, PA
Allyson Larkin, ABIM
Pittsburgh, PA
Jordan E. Lateiner, MS
Jersey City, NJ
Tera L. Lavoie, BS, MS
Chicago, IL
Joshua Lawson, BSc, MSc, PhD
Saskatoon, SK, Canada
Donald R Lazarus, MD, FACP
Humble, TX
Huong Thi Thu Le, MD
Ho Chi Minh City, Vietnam
Quyen Diem Le Nyugen, MD
Ho Chi Minh City, Vietnam
Joseph K Leader, PhD
Pittsburgh, PA
Del Leary, MA, MSc
Boutiliers Point, NS, Canada
Julie Gunnells Ledford, PhD
Durham, NC
Laurie Lee
RTP, NC
Yeon Joo Lee, MD
Seoul, Korea, Republic of
Ye Ji Lee, BS, MD
Seoul, Korea, Republic of
Hyun-Kyung Lee, DrMed
Busan, Korea, Republic of
Cindy KaYee Lee, MD
Olney, MD
Changjin Lee, DSc
Boston, MA
Andrew Lee, MD
Bronx, NY
Ji Yeon Lee, MD
Seoul, Korea, Republic of
Suh Young Lee, MD
Seoul, Korea, Republic of
Alfredo Lee Chang, MD
Bronx, Paraguay
Efrat Lelkes, MD
San Francisco, CA
Elizabeth Ann Lendermon, MD
Baltimore, MD
Tracy Leong, MBBS
Melbourne, Victoria, Australia
Janice Leung, MD
Seattle, WA
Barbara Lee LeVarge, MD, BS
Boston, MA
Matthew John Leveno, MD
Dallas, TX
Guangxi Li, MD
Rochester, MN
Jeff Lilly, MD
Carrollton, TX
Sharlene R Lim, PhD
Brisbane, CA
Sneha Saurabh Limaye, MBBS
Pune, Maharashtra, India
Yannbor Lin, MD
Boston, MA
Julie Linek, MD
New York, NY
Altay Lino De Souza, MD
Sao Paulo, Brazil
Thomas Linton, MBBS
Farnborough, United Kingdom
Yuru Liu, PhD
Chicago, IL
Xiaoqui Liu, MD
San Diego, California
Vincent Liu, MD
Redwood City, CA
Kenneth Liu, BSc(Hons), PhD
La Jolla, CA
Shu Fang Liu, DrMed, PhD
Manhasset, NY
Christian M. Lo Cascio, MD
Zurich, Switzerland
Hilmi Lockman, MBChB
Exeter, Devon, United Kingdom
Stuart Loesch, MBA
North Wales, PA
Isabelle Carla Lohman
Tucson, AZ
Rik Loijmans, MD, MSc
Amsterdam, Netherlands
Andrea Lomp, MD
London, United Kingdom
Marina Londero, DrMed
Santa Maria, Rio Grande do Sul, Brazil
Charron Long, PharmD
Lakeville, MA
James A. Long, MD
Waynesboro, VA
Kevin Looi, BSc(Hons)
Perth, Western Australia, Australia
Hillary Loomis-King, MD
Plymouth, MI
Javier Lopez, DrMed
Davis, CA
Annette Lopez, MD
Tucson, AZ
Peter Lucas, MSc
Horsham, West Sussex, United
Kingdom
Robert V. Lumsden, BSc
Dublin, Ireland
Maria Weitoft Lundstrom, MSc
Lund, Sweden
Christie Lundwall, MS
Beaumont, CA
Riad Lutfi, MD
Cincinnati, OH
Simon MacKenzie, BSc(Hons), PhD
Glasgow, United Kingdom
Satish Kumar Madala, PhD
Cincinnati, OH
Lindsey Madden, MD
Boston, MA
Jamil Madi, MD
Brownsville, TX
Jaime Madrigano, MPH
Boston, MA
Thiago Thomazmafort
Niteroi, Brazil
Eugenio Fernandes Magalhaes, MD
Pouso Alegre, Minas Gerais, Brazil
Maziar Maghsoodnia, PharmD
Moraga, CA
Grace Maguire, MBA
New York, NY
Aamir Magzoub, MSc, MBBS
Khartoum, Sudan
Poornima Mahavadi, PhD
Giessen, Germany
Breion Marie Mailloux
San Antonio, TX
Christof J. Majoor, MD
Amsterdam, Netherlands
Garbo Mak, MD
Houston, TX
Judith Choi Wo Mak, PhD
Hong Kong
Kanako Maki, MD
Sapporo, Japan
Toluwalope Makinde, PhD
Omaha, NE
Hideki Makino, MD
Kamogawa, Tiba, Japan
Meenakshi Malik, PhD
Albany, NY
Patrick Malloy
South San Francisco, CA
Rendani Clarence Mamathuba, MBChB
Pretoria, Gauteng, South Africa
Jean-Claude Mamputu, PhD
Montreal, Quebec, Canada
Erin K. Mangan, PhD, BS
Independence, OH
Sarah Lynn Mann, MD
St. Louis, MO
Luisa Fernanda Manrique Acevedo,
MD
Bogota, Cundinamarca, Colombia
Kamran Manzoor
Knoxville, TN
Yaroslav Marchenkov, MD
Moscow, Moscow, Russian Federation
Nicolas Marcoux, MD
Quebec, Canada
Jaime Maroney, BA
Research Triangle Park, NC
Jaman Maroni, MD
Basking Ridge, NJ
Milomir Misha Marovac, MD
Ottawa, ON, Canada
Lucila Marquez, MD
Houston, TX
Emilia Jumbe Marsden, MD
Lusaka, Zambia
Diego Jose Maselli Caceres, MD
San Antonio, TX
Richard S. Maser, PhD
Bar Harbor, ME
Tinni T. Maskoen, MD
Bandung, West Java, Indonesia
Rebecca H Mason, MBChB,
MRCP(UK)
Taunton, Somerset, United Kingdom
Vincent Masse, MD
Sherbrooke, QC, Canada
Claire H. Masterson, BS, MS
Galway, Ireland
Takeshi Masuda, MD, BM
Hiroshima, Japan
Zahra Iskra Mathura, MD
Louisville, Kentucky
Renato L. Matos, MS
Criciuma, Santa Catarina, Brazil
Gert-Jan Mauritz, MSc
Amsterdam, HV, Netherlands
Robert Justin May, BS
Arvada, CO
Annyce Mayer, MD, MSPH
Denver, CO
Mary Kathleen Mazel, MD
Los Angeles, California
Jason D. McCarl, MD
Portland, Maine
Cormac McCarthy, BMedBiol, MB,
MRCP(UK)
Dublin, Ireland
Rosa Clare McCarty, BSc(Hons), PhD
Clayton, Melbourne, Victoria, Australia
Michael McCaskill, PhD, MPH
Omaha, NE
Laura Ann McCauley, MD
Saint Paul, MN
Deborah H. McCollister, RN, BSN
Aurora, CO
Melissa Jane McDonnell, MBBS
Galway, Ireland
Colleen McEvoy
Chicago, IL
Alexandra McGann, DrMed
New York, NY
Patricia McHale, BS(Hons), MSc
Galway, Ireland
Mary McKenzie, BSc, MA, MD
Philadelphia, PA
Sally H. McLaughlin, RN, MSN
San Francisco, CA
Kimmie Kohlhase McLaurin, MS
Gaithersburg, MD
Jared Milligan McLendon, BS
Mobile, AL
Sarah Margaret McMullen, FRCPC,
MSc, BS(Hons), MD
Halifax, NS, Canada
Carla Sue McSpadden, BP, RPh
Paoli, IN
Nikhil Kumar Meena, MD
Little Rock, AR
John Meertens, MD
Groningen, Netherlands
Hiren Mehta, MD
Charleston, SC
Shirley Hsin-Ju Mei, PhD
Ottawa, ON, Canada
Silke Meiners, PhD, BSc
Munich, Germany
Catherine Anne Meldrum, MS, RN
Ann Arbor, MI
Erik Melen, MD, PhD
Stockholm, Sweden
Daniel Deutsch Melley, MBBS,
MRCP(UK), PhD
London, United Kingdom
Stephen Mendel, PharmD
Solon, OH
Eliana Mendes, MD
Miami, FL
Manuel Merlos
Palau-Solita I Plegamans, Spain
Traian Mihaescu, CRT
Iasi, Romania
Stefan Mihaicuta, CRT
Timisoara, Romania
Florin Mihaltan, CRT
Bucharest, Romania
Srboljub M. Mijailovich, PhD
Newton, MA
Bruce A. Miller, MD
Sandia Park, NM
Joanne Miller, MBChB
London, United Kingdom
Graham Andrew Miller, MRCP(UK),
MBChB
Coatbridge, United Kingdom
Douglas Miniati, MD, BA
San Francisco, CA
Bogdan Miron, CRT
Bucharest, Romania
Rajesh Chandra Mishra, MD
Ahmedabad, Gujrat, India
Sean Mobberley, BS
Iowa City, IA
Mohammed Mogri, MBBS
Buffalo, NY
Firdaus Mohamed Hoesein, MD
Utrecht, Netherlands
Manish Mohanka, MD, MPH
Lakewood, OH
Helena Molero, MD
Chicago, IL
Kevin Molloy, MB
Dublin, Ireland
Luis Fernando Moncayo
Quito, Pichincha, Ecuador
Scott Moomaw, MBA
Research Triangle Park, NC
Joshua J. Mooney, MD
San Francisco, CA
Christian Raul Morales, MD
Philadelphia, PA
Daniel Moreira
Houston, TX
(continued on page 11)
ats news | vol.37 no.5 | may 2011

NEWS
(continued from page 10)
Daiana Moreira Mortari, PT
Passo Fundo, Rio Grande do Sul,
Brazil
Ricardo Mosquera
Bogota, Colombia
Ed Mougey, PhD
Jacksonville, FL
Xueru Mu, MD
New York, NY
Joseph C. Mueller, MD
Lexington, KY
Subhendu Mukherjee, PhD, MSc, BSc
Hamilton, ON, Canada
Sathish Mundayoor, PhD
Trivandrum, Kerala, India
Sarah Muni, MD
Walnut Creek, CA
Koji Murakami, MD
Sendai, Japan
Benjamin Joseph Murdock, PhD
Ann Arbor, MI
Lorraine Murphy, PhD, PharmD
Horsham, West Sussex, United
Kingdom
Michelle Murray, BA, MBChB,
MRCP(UK)
Dublin, Ireland
Gimbada Benny Mwenge, MD
Brussels, Brabant, Belgium
James Stephen Myerson, MBBS, BSc,
MRCP(UK)
Crawley, West Sussex, United
Kingdom
Namrata Nag, MBBS
Amherst, NY
Jairaj Parameswaran Nair, MD, BM
BCH
Mumbai, Maharashtra, India
Hiroyuki Nakamura, MD, PhD
Sakaide-city, Kagawa, Japan
Talat Nasim, BS(Hons), MSc, PhD
London, United Kingdom
Krishna Navale, MBBS
Davangere Karnataka, India
Kazem Navari, MD
Bandarabbas, Iran (Islamic Republic
Of)
Cheryl Needham, RRT
Monroeville, PA
Thomas Andrew Nelson, MBChB,
BSc(Hons)
Lancaster, United Kingdom
Darlene Nelson
Rochester, MN
Flavia Baggio Nerbass, PT
Sao Paulo, Brazil
Dawn Catherine Newcomb, PhD
Nashville, TN
Richard Nho
Minneapolis, MN
Lori Dwyer Nield, PhD
Aurora, CO
Nikolaos M. Nikolaidis, PhD
Cincinnati, OH
Michiyoshi Nishioka
Fukui-city, Fukui-prefecture, Japan
EusebiusHenry Nkyimbeng Takwi, PhD
Windsor Mill, MD
Yayoi Nomura, MD
Matsumoto, Japan
Peter Norris, PhD
Burlington, MA
Stasha Novakovic, MD
Gainesville, FL
Caroline Anne O’Dowd, BM BCH
Glasgow, United Kingdom
David Noel O’Dwyer, BM BCH,
BMedSci
Cork, Ireland
Michael O’Fathartaigh, MBChB
Adelaide, SA, Australia
Sarah O’Neill, BN
Mount Pleasant, SC
Sean O’Quinn, MPH
Gaithersburg, MD
Maen Obeidat, BPharm
Nottingham, United Kingdom
Sebahat Ocak, MD
Yvoir, Belgium
Cesar E. Ochoa Perez, MD
Houston, TX
Sam Oh
San Francisco, CA
Masahiko Oka, MD, PhD
Mobile, AL
Masahide Oki, MD
Nagoya, Japan
Carla Tatiana Martins Oliveira, MD
Porto Alegre, Rio Grande do Sul, Brazil
Jose Gustavo Oliveira, MD
Rio de Janeiro, Brazil
Omoniyi Omojowold Omotoso, MD,
MPH
Oakland, California
Edwin Ostrin, MD, PhD
Albany, CA
Katie Overdier, BS(Hons)
Denver, Colorado
Aylin Ozgen Alpaydin
Manisa, Turkey
Maria Cristina Alochio De Paiva, MD
Cariacica, ES, Brazil
Isabel Palacios Ortega, MD
Bogota, Colombia
Paramita Palchaudhuri, MBBS,
MRCP(UK)
London, United Kingdom
Ileana Valeria Palma, MD
Buenos Aires, Argentina
Tatsiana Palvinskaya, MD
Hamden, CT
Ashok Kumar Panjwani, RRT
KaraciI, Sindh, Pakistan
Luca Paoletti, MD
Charleston, SC
Demosthenes G. Papamatheakis, MD
Rancho Cucamonga, CA
Harikrishnan Parameswaran, PhD
Boston, MA
Helen Parfrey, BM BCH, PhD
Cambridge, United Kingdom
Purvi Parikh, MD
Cleveland, OH
Hyun-Jung PARK, RN
Seoul, Korea, Republic of
Sung Soo Park, MD
Seoul, Korea, Republic of
Edith A. Parker, DrPH, MPH
Iowa City, IA
Elizabeth Christina Parsons, MD
Seattle, WA
Sailaja M. Paruchuri, PhD
Cleveland, OH
Karakis Pasaoglu_Gulden, MD
Istanbul, Turkey
Kelly Marie Paschke, BA
Russell, OH
Christopher Pascoe, BS
Vancouver, BC, Canada
Kevin Patel, MA, MBChB
Seattle, WA
Amit Suresh Patel, MRCP(UK), MBBS
London, United Kingdom
Rakesh P. Patel, PhD
Birmingham, AL
Anik Patel, MD
Mineola, NY
Neil Patel, MD
Hershey, PA
Kinnaresh S. Patel, MD
Winston Salem, NC
Rishi Bipin Patel, BS
Piqua, Ohio
Neil Patel, MBBS, MRCP(UK)
Loughborough, Leicestershire, United
Kingdom
Paresh D. Patel, MD
Houston, TX
Rajiv Patni, MD
South San Francsico, CA
Pauline A. Patrick, BSPh
Brentwood, TN
ats news | vol.37 no.5 | may 2011
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
following domestic and international members who joined the ats between January 1, 2011 and march 31, 2011.
Manju P. Paul, MBBS
Syracuse, NY
Grace Rebecca Paul
Pittsburgh, PA
Zarogoulidis Paul
Athens, Greece
Roxane Paulin, MSc
Quebec, Canada
Pinar Pazarli, MD
Beylikduzu, Istanbul, Turkey
Mary Ann Penalosa, MD
Tacvobam City, Leyte, Philippines
Alidda Peoples, UAP, AD
Menifee, CA
Tonio Pera, MScPharm
Groningen, Netherlands
Ingrid Viviana Perez Perdomo, MD
Bogota, Colombia
Irene Q. Permut, MD
Philadelphia, PA
Antonio Pesenti, MD
Monza, Italy
Misha Peter, MD
Philadelphia, PA
Jonathan Grant Peter, MBChB
Cape Town, Western Cape, South
Africa
Bryan Petersen, BA
Ann Arbor, MI
Patrick Petitpretz, MD
Le Chesnay, France
Joe Philip, BSc, MD
Astoria, NY
Lucia Piccotti, PhD
Houston, TX
Philipp Andreas Pickerodt, MD
Seattle, WA
Tim Pigot
Foster City, CA
Sophia M. Pillai
Great Neck, NY
Javier Alfonso Pinedo Onofre, ChB, MS
San Luis Potosi, Mexico
Audrey Piotrostanalzki, MD
Bogota, Colombia
Michael Pisano, PhD
Ann Arbor, MI
Jonathan Plumb, MD
Manchester, United Kingdom
William Thomas Pluss, MD
Denver
Christophe Poirier, PhD
Augusta, GA
Arvind Jayaraj Ponnambalam, MD
Brooklyn, NY
Monica Pop, CRT
Cluj Napoca, Romania
Greg Porta
Mason, OH
Michael Anthony Portelli
Nottingham, Nottinghamshire, United
Kingdom
Adelito Descallar Posas, MD
Puerto Princesa, Philippines
Yannick Poulin, MD
Sherbrooke, QC, Canada
Carol J Pozsik, MPH, RN
Smyrna, GA
Gonzalo David Prada
Bogota, Colombia
Silvia Liana Pradan, MD
Toronto, ON, Canada
Bharat Ved Prakash, MD
Pittsburgh, PA
Aditi Prakash, MBChB
Liverpool, United Kingdom
Steven Paul Praske, DO
San Diego, CA
Michele Prater, CPNP
Temple, TX
Yuwarat Premprayoonwongsa, MD
Bangkok, Potumwan, Thailand
Mareike Price, MD
Shankill, Dublin, Ireland
April Price, BS(Hons), MD
London, Canada
Steven Proper, BS(Hons)
East Lansing, MI
Thomas Przybysz, MD
Pittsburgh, PA
Steven Pugliese, MD
Baltimore, MD
Zudin Puthucheary, MBBS, BMedSci
London, United Kingdom
Michael Timothy Putt, MBBS
Brisbane, Australia
Asif Qaseem, PhD
Uxbridge, United Kingdom
Jordan Querido, MSc
Vancouver, BC, Canada
Hisham Fozi Qutob, MD
Winston-Salem, NC
Zakwan Quwatli, MD
Gurnee, IL
Silvia Rain, MSc
Amsterdam, Netherlands
Thottuvai Rajasekar
San Ramon, CA
Sastia Rakhma, GP
Malang, East Java, Indonesia
Ravisankar A. Ramadas, DVM, PhD
Arlington, MA
Gurdyal S. Ramgaria, PhD
Chandigarh, Chandigarh, India
Evan Ramser, DO
Lewiston, ME
Ujala Rana, PhD
Aurora, CO
Kapil Krishna Rangavajhala, MD,
MBBS
Houston, TX
Elia Ranzato, BS, PhD
Alessandria, Italy
Devika Radhika Rao, ABP
Boston, MA
Suphagaphan Ratanamaneechat, MD,
MPH
Cleveland Heights, OH
Naveen Rawat, MBBS, MD
Hartsdale, NY
Andrew D. Ray, PT, PhD
Buffalo, NY
Syed M. Raza, MD
Rochester Hills, MI
Kashif Raza, MD
Minneapolis, MN
Jagadeshwar G Reddy, MD
Indianapolis, IN
Elizabeth F. Redente, PhD
Denver, CO
Megan Anne Rees, MBBS
North Melbourne, Victoria, Australia
John Patrick Reilly, MD
Philadelphia, PA
Philippe Reix, MD, PhD
Bron, France
Donna C. Rennie, PhD
Saskatoon, SK, Canada
Andreas Wolfgang Reske, MD
Leipzig, Germany
Ramesh Revanna, MBBS
Bangalore, Karnataka, India
Morgan E. Richard, MBA
Research Triangle Park, NC
Thomas J. Richards
Pittsburgh, PA
Robin Richardson, BA
Chula Vista, CA
Bradley Winston Richmond, MD
Nashville, TN
Stefan Richter, BSc(Hons), MD
Boston, MA
Kathleen Rickard, MD
Raleigh, NC
Philippe Rieder, DrMed
Pompaples, Switzerland
Chris H. Rikers, MD
Amsterdam, Netherlands
Katherine A. Ringo, BS
Rochester, New York
Cristobal F. Risquez Cordovez, MD
Boston, MA
Rick Roberts
North Wales, PA
Claire Robertson, MS
Irvine, CA
Iulia Cristina Roca, MD, BM
Iasi, Romania
Mihai Roca, Bmed, MD
Iasi, Romania
Rich Rosenthal
Louisville, CO
Blair Roszell, PhD
Philadelphia, PA
Marios Roussos, MD, FRCPC
Vancouver, BC, Canada
Courtney Rowan, MD, BS(Hons),
BA(Hons)
Indianapolis, IN
Dmitry Rozenberg, MD, BS
Toronto, ON, Canada
Donald Ruhrmund, MA
San Francisco, CA
Gerrina Ruiter, MD
Amsterdam, Netherlands
Nisreen Rumman, MD
Milwaukee, WI
Erilynn Russo Heinrichsen
La Jolla, CA
Daniel Mihai Rusu, MD
Mount Pleasant, SC
Takuro Sakagami, MD, PhD
Niigata, Japan
Ozlem Salman Seyer, MD
Yenimahalle, Ankara, Turkey
Sundeep Santosh Salvi, MD, PhD
Pune, Maharashtra, India
Paula Chaves Sampaio, MD
Sao Paulo, Vi Romana Lopa, Brazil
Halim Samsirun
Jambi, Jambi, Indonesia
Vinny Oommen Samuel, MD
Jacksonville, Florida
Eileen Samy, PhD
Nutley, NJ
Jarmin Sanchez, MD
Guayaquil, Guayas, Ecuador
Amarinder S Sandhu, MBBS, MSc
Roanoke, VA
Scott Aaron Sands, BSc, PhD
Cambridge, MA
Joanna Veruschka Santeliz, PhD, MD
Barquisimeto, Lara, Venezuela
Joel M. Santiaguel, MD
Monila, Philippines
Alex Sapir, MBA
Research Triangle Park, NC
Houtan Sareh, MD
Baltimore, MD
Kathleen Elizabeth Sartoris, PharmD
New York, NY
William Clinton Sasser, ABP, BA
Birmingham, AL
Robyn Scatena
New Haven, CT
Willem-Jan Schellekens, MD
Nijmegen, Netherlands
Heidi Schilter, PhD, BSc
Sydney, NSW, Australia
Michael Schivo, MD
Sacramento, CA
Audrey Lynn Schoonmaker, BN
Phoenix, AZ
Charles Clement Schraa, BPharm,
RPh, PharmD
Mechanicsville, VA
Benjamin Schultze, APRN, BC,
ACNPC, AHI, BS, CCRN, MScN, MS
San Francisco, MN
Jacqueline Schwarz, DO
Park Ridge, IL
Sabrina B.G. Schwingel, MD
Sao Bento do Sul, Brazil
Nathaniel L. Scott, BA, MD
Minneapolis, MN
Tara Seaman, BScN, RN
Batavia, OH
Joseph Seaman, MD
Cincinnati, OH
Kay Choong See, MBBS, MRCP(UK)
Singapore
Amanda Seeff-Charny
New York, NY
Howard Joel Seeherman, PhD, DVM
Cambridge, MA
Max Anthony Seibold, PhD
Denver, CO
Benjamin Jason Seides
New York, NY
Carlos Sendon, RPSGT, MD
Lima, Peru
Sonali Sethi, MD
New York, NY
Lisa Shackelton, DipMicrobiol, DSc
Montreal, QC, Canada
Chirag Shah, MD
Farmingville, New York
Arti Dhawal Shah, MBBS
Vadodara, Gujrat, India
Arpan C. Shah, MBBS
Baroda, Gujarat, India
Neeraj Mukesh Shah, BSc(Hons)
New Malden, Surrey, United Kingdom
Mohammed Arif Shaikh, MD
El Dorado Hills, CA
Zarrin Shaikh, DrMed, MD
London, United Kingdom
Cary B. Shames, DO
Littleton, CO
Lisa Marie Shapcott, MD
Tacoma, WA
Cyrus Shariat, MD
New York, NY
Irtza Sharif, MD
Newark, NJ
Bharat Bhushan Sharma, MD
Jaipur, Rajasthan, India
Keshav Raman Sharma, BM BCH,
BMedSci
Galway, Ireland
Michael C. Shen, MD
Ann Arbor, MI
Ying Shi, MD
Boston, MA
Yuanyuan Shi, PhD
Albuquerque, NM
Natalie Rebecca Shilo, ABP
Montreal, QC, Canada
Tadasuke Shimokawaji, MD
Tokorozawa, Saitama, Japan
Hyun-Woo Shin, MD, MSc
Seoul, Korea, Republic of
David Shitrit
Jerusalem, Israel
Amitabh Das Shukla, MD
Gorakhpur, India
Yajur Shukla, BSc(Hons), MD
London, ON, Canada
Murali Shyamsundar, MBBS,
MRCP(UK)
Belfast, Antirm, United Kingdom
Paschalis Sideras, PhD
Athens, Greece
Aman Sidhu, BSc(Hons), MD
Vancouver, BC, Canada
Jessica C. Sieren, PhD
Iowa City, IA
Ioanna Sigala, MD
Montreal, QC, Canada
Anurag Singh Sikarwar, MSc
Winnipeg, MB, Canada
Santh V. S. Silparshetty, MD
Bethlehem, PA
Vinicius Lemos Silva, MD
Rio De Janeiro, Brazil
Arthur J. Silverstein, DO
Paradise, California
Branko Simeunovic, MD
Windsor, ON, Canada
Benjamin David Singer, MD
Chicago, IL
Vikas Singh, MBBS
Pittsburgh, Pennsylvania
Sanjeev Sinha, MD
New Delhi, India
(continued on page 12)
11

(continued from page 11)
Christopher Siracusa, MD
Akron, OH
Shaun H. Sizemore
North Wales, PA
Scott Skibo, MD
La Crosse, WI
Anna Skor, MD
Los Angeles, CA
Frans Skosana, MBChB
Randburg, Gauteng, South Africa
Stanislav Anatolievich Skryabin, ChB
Murmansk, Russian Federation
Craig Smallwood, BS, RRT
Boston, MA
Patrick Riley Smith, DO, BA
DuPont, WA
Alexandra Smith, MD
Edmonton, AB, Canada
Cardinale Smith, MD
East Elmhurst, NY
Robert Smyth, BM BCH
Dublin, Ireland
Maria Raquel Soares, BM
Sao Paulo, Brazil
Othman Solaiman, MD
Toronto, ON, Canada
Siva Kumar Solleti, PhD
Rochester, NY
Jae-Uk Song
Seoul, Korea, Republic of
Atsushi Sorita, MD
New York, NY
Graziella Soulban, PhD
Montreal, Quebec, Canada
Brian Derris Southern, MD
Cleveland Heights, OH
Daniela Carla Souza, MD
Sao Paulo, Brazil
Fabio Josa Fabracio de Barros Souza,
MSc
Criciuma, Santa Catarina, Brazil
Vidar Soyseth, PhD, MD
Lorenskog, Norway
Al Sperry, RRT
Windermere, FL
Mark Louis Splaingard, MD
Columbus, OH
Martin Springsklee, MD
Berlin, Germany
Demetri Spyropoulos, PhD
Charleston, SC
Usha Rani Sri Ram, MRCP(UK), MBBS
Shah Alam, Selangor, Malaysia
Michael Makumbi Ssentamu, BM
Canberra, Australia
Christina Leigh Stallings, PhD
St. Louis, MO
Darina Stankeyeva, MD
Decatur, GA
Gregg J. Stashenko, MD
Asheville, NC
Shawna Steadman, NP
Worcester, MA
Marijke van der Steen, MD
Ede, Netherlands
Scott Richard Stewart, MD
Johns Island, SC
William Stigall, MA, MD
Dallas, TX
Ian Steven Stone, MRCP(UK), MBBS,
BSc(Hons)
London, United Kingdom
Andrew Stone, MBBS
Sydney, Australia
Paul Strachan, MD
Stony Brook, NY
Temima Strauss, BA
Bergenfield, NJ
Amanda Rae Stream, MD
Denver, CO
Hans Struyven, MD
Mienen, Belgium
Bridget Stuart
Baltimore, MD
Margarita Maria Suarez, MD
Boston, MA
12
NEWS
Deepak Subramanian, MRCP(UK),
BS(Hons), MBChB
Birmingham, United Kingdom
Ganesh K. Subramanian, MD
Edmonton, AB, Canada
Beth Sufian, JD
Houston, TX
Tantani Sugiman, MD
Jakarta, Indonesia
Maria B. Sukkar, PhD
Sydney, Australia
Ahmed Sulieman Daoud, MD
Royal Oak, MI
Shawn Sun, PhD
Jersey City, NJ
Jacob Sunshine, BA
Seattle, WA
Kajorn Suntrapiwat, MD
Phitsanulok, Thailand
Anu Suri, MD
New York, NY
April Retno Susilo, MD
Jakarta Barat, Indonesia
Erika Nancy Sutanto, PhD
Perth, Australia
Melissa J. Suter, PhD
Boston, MA
Jimmy Suvante, MD
Silver Spring, MD
Sunil Swami, MD, BS
Warwick, RI
Pawel Piotr Szczesniak, MSc
Bad Nauheim, Hessen, Germany
Denisse Veronica Tafur
Guayaqul, Guayas, Ecuador
Karla Tafur
Lima, Peru
Ann Taite, RN,
Kingston, ON, Canada
Ryohei Takahashi, MD
Yokohama, Kanazawa-ku, Japan
Seyedtaghi Takyar, MD, PhD
New haven, CT
Nick P. Talbot, BA, BM BCH, PhD,
MRCP(UK)
Oxford, United Kingdom
Stanley Tam, PhD
Davis, CA
Tsutomu Tamada, MD
Sendai, Japan
Aik Hau Tan, MBBS
Singapore, Singapore
Hui-leng Tan, MBBS
London, United Kingdom
Daniel Tan, ACNS-BC
Manila, Philippines
Xiaoxiao Tang, PhD
Iowa City, IA
Laura Ann Tanner, BM BCH
Newcastle upon Tyne, United Kingdom
Nichole T. Tanner, MD
Charleston, SC
Sasipa Tanyaratsrisakul, PhD
Denver, CO
Versha Rani Taparia
New York, NY
Sarah Tapyrik, MD
New York, NY
Yasir Tarabichi, MD
Lakewood, OH
Lauren Marie Tavani
Wilmington, DE
Hock Luck Tay, BMedSci
Newcastle, Australia
Darren Tayama, MD
Foster City, CA
Michelle Taylor, NP
Bentonville, AR
Jamaree Teeratakulpisarn
Khon Kaen, Thailand
Eef Telenga, MD, MSc
Groningen, Netherlands
Luis Jaime Tellez, MD
Bogota, Colombia
Brian A. W Temple, MD
Jackson, MS
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
ATS WelcomeS NeW memberS
Christian Thomas Tencza, MD
Lancaster, OH
Victor J. Test, MD
Tulsa, OK
Junichiro Tezuka, MD
Koga, Fukuoka, Japan
Jyoti V. Thaikoottathil
Denver, CO
Katherine Thain, BSc(Hons)
Vancouver, BC, Canada
Cindy Thamrin, PhD
Glebe, Australia
Arthi Thangaraj, MD
Braintree, MA
Pham Thi Ngoc Thao, PhD
Ho Chi Minh City, Vietnam
Theepha Thayalakulasingam, MD
River Ridge, Louisiana
Balamayooran Theivanthiran
Baton Rouge, LA
Justin Thomas, MD
Pittsburgh, PA
Johnson Thomas, PhD
Skokie, IL
Anchana Thongyam, MD
Chanburi, Thailand
Kimberley J. Tiller, RN, MPH
Stamford, CT
Sophie Timmins, MBBS
Camperdown, Australia
Brian Terry Tinch
Durham, NC
Gabrielo Mauro Tini, MD
Zurich, Switzerland
Ann Tisthammer, RRT, BSN
San Diego, CA
Anupama Tiwari, MD
Ann Arbor, MI
Hirokazu Tojima, CIC, MD
Tokyo, Japan
Rebecca Lyn Toonkel, MD
Miami Beach, FL
Cherie Aimee Torres-Silva, DrMed,
MSPH
Cincinnati, OH
Jennifer Whitney Toth, MD
Lebanon, PA
Sarah Elizabeth Totten, BA, BS,
M(ASCP)
Denver, CO
Jennifer Totten
San Francisco, CA
Syed Zulkharnain Tousheed, MD
Bangalore, Karnataka, India
Paul Cao Dat Tran, MD
Sherbrooke, QC, Canada
Erika Treptow, MD
Sao Paulo, Brazil
Anne Marie Trese, PharmD
Colorado Springs, CO
Anil Julius Trindade, MD
Cambridge, MA
Pia Trip, MD
Amsterdam, Netherlands
Chu-Lin Tsai, MD, DSc
Houston, TX
Ming-Ju Tsai, MD
Kaohsiung, Taiwan
Ronny Tschokonte, MD
Rochester Hills, MI
Doris B. Tse
New York, NY
Will Tseng, MD
Sacramento, CA
Chia-Cheng Tseng, MD
Kaohsiung, Taiwan
Grace Tuaf-Toro, MRCP(UK), MBBS
London, United Kingdom
Katherine L. Tuggle, BS
Trussville, AL
Scott E Turcotte, BSc(Hons)
Kingston, ON, Canada
Alexey Tyryshkin, PhD
Houston, TX
Zeynep Zeren Ucar, MD
Izmir, Turkey
Elif Ucar Yilmazel, MD
Erzurum, Turkey
Jose Correa Ulloa, MD
Guayaquil, Ecuador
Ruxandra Ulmeanu, CRTT
Bucharest, Romania
Srinivasa R. Upputuri, MBBS
St Ann’s Bay, Jamaica
Thomas Urbania, MD
San Francisco, CA
Robert Urman, MSc
Los Angeles, CA
Kaoru Uto, DrMed
Matsudo City, Chiba, Japan
Jarin Vaewpanich, MD
Pathumtani, Thailand
Neha R. Vagadia, DO
Boston, MA
Prashant Vaishnava, MD
New York, NY
Juan Carlos Valerio-Rojas, MD
San Jose, San Jose, Costa Rica
Almir Jose Dias Valverde, MD
Campinas, Sao Paulo, Brazil
Marielle Van De Veerdonk, BSc
Amsterdam, Netherlands
Elske Van Den Berg, MD
Waddinxveen, Netherlands
Hester Van Der Vaar
Groningen, Netherlands
Mark van Iperen
Wageningen-Hoog, Netherlands
Zachary Van Rheen, BS
Aurora, CO
Lauren Jodi Van Scoy, MD
Philadelphia, PA
Alfred Leonard van Steveninck, MD,
PhD
Eefde, Netherlands
Patricia Van Velzen, MD
Amsterdam, Netherlands
Alexander Vang, BA
Providence, RI
Rhea Varughese, MD
Calgary, AB, Canada
Yanira Riffo Vasquez, MSc, PhD
London, United Kingdom
Maria Elena Vega Sanchez, MD
Philadelphia, PA
Haviva Veler, MD
Hartsdale, NY
Philip Alan Verhoef, MD, PhD
Chicago, IL
Vishal J. Verma, MD
Brooklyn, NY
Kaninika Verma, MD
Albuquerque, New Mexico
Daniela Verri, PD
Milan, Italy
Rupert Vessey, MRCP(UK), PhD
Rahway, NJ
Elias Vieda Silva, MD
Cali, Colombia
Alicia Viglione, MBA, MS, BS
New York, NY
Filomena Hazel Villa, ABP
Alameda, CA
Francisco C. Villafuerte, DSc
Lima, Peru
Genevieve Vincent, PhD
Montreal, Quebec, Canada
Ivan Vishnivetsky, MD, PhD
Donetsk, Ukraine
Julie Christie Gutierrez Visperas, MD
Antipolo, Philippines
Thu Pham Minh Vo, MS
Can Tho, Ninh Kiev District, Viet Nam
Bryan Vo, MD
Fountain Valley, CA
Anneclaire Victoria Vroegop, MD
Amsterdam, North Holland,
Netherlands
Rolf Wagenaar
New York, NY
Barbara Wagner, MLT(ASCP), BSc
Saint Petersburg, FL
Ghousia Wajida, MD
Lewisville, North Carolina
David Wallace, MD, MPH, RDMS
Pittsburgh, PA
Sarah Ruth Walmsley, BM BCH, PhD
Sheffield, United Kingdom
John W. Walsh
Miami, FL
Rui Wang, AAS
New York, NY
Ran Wang, PhD
Hefei, Anhui province, China
Zhaoxi Wang, MD, PhD
Boston, MA
Guoqing Wang, DrMed
New York, NY
Pingli Wang, PhD
New Orleans, LA
Meiqin Wang, PhD
Denver, CO
Yang Wang, MD, PhD
Chicago, IL
Ying Wang, MD, PhD
Chapel Hill, NC
Earl Ward, PharmD
Suwanee, GA
William C. Warger, PhD
Boston, MA
Stephen Wedgwood, BS(Hons), PhD
Chicago, IL
Jason Wells, BSc, MD
Denver, CO
W.N. Welvaart, MD
Tiel, Netherlands
MeiQian Weng, PhD, MD
Charlestown, MA
Joanna Weyde, DrMed
Bad Soden, Germany
Sam White, PharmD
Foster City, CA
Vicky Holets Whittemore, PhD
Silver Spring, MD
Allison Widlitz, MS, PA
South San Francisco, CA
Marlies Wijsenbeek, MD
Rotterdam, Netherlands
Kelli Wilson
South San Francisco, CA
May L. Wilgus, MD
New York, NY
Stephen J. Williams, PhD
Beverly Hills, CA
Peter Alan Williamson, BM BCH
Dundee, United Kingdom
Chelsea Alisa Willie
Chicago, IL
Andrew Wilson, MD, ABIM
Minneapolis, MN
James Wilson, MD
Murphy, TX
Chad Witt, MD
St. Louis, MO
Catherine Wittman, MD
Pittsburgh, PA
Bob Wolken, BS, RRT
Littleton, CO
Christine Won, MD
New Haven, CT
Michelle Wong, BM BCH
Johannesburg, South Africa
Henna Wong, MBBS, MRCP(UK),
BSc(Hons)
Southampton, United Kingdom
Chanikarn Mint Wongviriyawong, PhD
Cambridge, MA
Jeremy Wrobel, MBBS, MPH
Melbourne, VIC, Australia
Richard Wu, MD
Weehawken, NJ
Zhong-xin Wu, DrMed
Morgantown, WV
Lishi Xie
Chicago, IL
Xiao Xu, PhD
Gaithersburg, MD
Shuyun Xu, MD, PhD
Wynnewood, PA
Jin-Fu Xu, DrMed, SM(ASCP)
Shanghai, China
Jianmin Xue, DrMed, PhD
Wexford, PA
Masami Yamazoe, PhD, DrMed
Denver, CO
Steve Yancey, MS
Apex, NC
Connie Lee Yang, MD
Toronto, ON, Canada
Rashele Yarborough, BS
New Haven, CT
Yuki Yasaka, MD
Los Angeles, CA
Yohei Yatagai, MD
Naka-gun, Ibaraki, Japan
Ashley Yegen, MD, MBA
South San Francisco, CA
Leyla Yilmaz Aydin, MD
Duzce, Turkey
Bian Yongjun, MD
Beijing, China
Hugo Hyung Bok Yoo, MD
Botucatu, Sao Paulo, Brazil
Jee-Hong Yoo, MD
Seoul, Korea, Republic of
Christina Yoon, MD, MPH
San Francisco, CA
Joyce Young, PharmD
Foster City, CA
Albert Ming Yu, MD
Los Angeles, CA
Jane J. Yu, PhD
Boston, MA
Jeong Yun Jeong, DrMed
Seoul, Korea, Republic of
Heidi Teresa Zafra, MD
Milwaukee, Wisconsin
Sarah Zaidi, MD
New York, NY
Felix Daniel Zamora, MD
Saint Paul, MN
Zbigniew Zaslona, PhD
Ann Arbor, MI
Vanessa A. Zavaletta, MD, PhD
Rochester, MN
Igor N. Zelko, PhD
Louisville, KY
Lan Zhao, PhD, MD
London, United Kingdom
Qing Zhao, DrMed
Beijing, China
Lei Zhou, MD, PhD
Houston, TX
Shutang Zhou, BSc, PhD
Durham, NC
David Zielinski, MD
Montreal, QC, Canada
Geert Jan Zijlstra, BMS
Groningen, Netherlands
Marlies Zwerink, MSc
Enschede, Netherlands
It pays
to be an
ATS member.
If you are not a
member of the
ATS, join today to
take advantage of
the many benefits
of membership.
To learn more,
please visit
www.thoracic.org.
ats news | vol.37 no.5 | may 2011

NEWS
ats ‘Hill day’: WHen Congress maKes Key
deCisions, ats is tHere
In late March, ATS members from across the United
States arrived on Capitol Hill to advocate on behalf of
patients with respiratory, critical care and sleep disorders,
as well as clinicians, researchers and allied healthcare
professionals who work in these fields. Although the
ATS is engaged in a constant dialogue with Congress
and the Obama Administration about a wide range
of regulatory and funding issues, the ATS message to
lawmakers on “Hill Day” was limited to four particularly
timely concerns: the need to sustain biomedical research
investments through the National Institutes of Health
(NIH) and the VA Research Program budgets, protecting
the Clean Air Act and taking action on COPD, which is
the third-leading cause of death in the U.S.
“With Congress in the midst of a heated discussion
about federal spending, the Society’s message about
preserving the NIH budget was both timely and
forceful,” said ATS President Dean E. Schraufnagel,
MD, who attended the advocacy event. “The House
of Representatives has already passed legislation that
would cut $1 billion from the NIH budget. Such a
cut would be devastating to science and, ultimately, to
patients, who are in need of better treatments and cures
for respiratory diseases.”
Prior to visiting a number of congressional offices,
James Kiley, PhD, director of the Division of Lung
Diseases at the National Heart, Lung, and Blood Institute,
gave ATS members an update on the advances the
institute has made in lung disease research. ATS “Hill
Day” participants sent a clear message to Congress about
the importance of research to public health and, given the
high cost of healthcare, the country’s economic well being.
Senator Sheldon Whitehouse (D-RI)
with ATS member Linda Nici, MD,
PAR member Carl Flately and ATS
member Dona Upson MD.
ats news | vol.37 no.5 | may 2011
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
ATS members Jim Patterson, MD,
J. Randall Curtis, MD, MPH,
Lynne Reinke, PhD, and James
Beck, MD.
ATS members also educated members of Congress
about the important biomedical research being
conducted with funding from the VA Research program.
In particular, the Society’s advocates urged Congress to
provide the resources necessary for the VA to upgrade
and improve its aging laboratory infrastructure.
“In addition to debating funding priorities,
Congress is also considering whether it should roll back
parts of the Clean Air Act,” Dr. Schraufnagel explained.
“Again, the House has already passed legislation that
would reduce the Environmental Protection Agency’s
authority to improve our nation’s air quality. ATS
members reminded lawmakers that the Clean Air
Act is an economic and public health success story.
In addition to preventing 160,000 premature deaths,
86,000 emergency room visits, 130,000 heart attacks
and 1.7 million asthma exacerbations each year, the
Clean Air Act also reduces healthcare costs.”
ATS members presented legislators with a recent
study that showed $30 in economic savings—mostly
from reduced healthcare expenditures—for every $1
spent on pollution control. Armed with this important
information, the Society’s members urged Congress to
reject any amendments to remove or delay the EPA’s
authority under the Clean Air Act.
Members also shared with senators and
representatives important facts about COPD, which is
affecting more Americans each year. They explained
why it is vital that the federal government pay attention
to this often overlooked disease and to support the
creation of a national NHLBI action plan respond to
the growing COPD epidemic.
ATS President Dean E. Schraufnagel,
MD, gave his representative, Danny
Davis (D-IL), a copy of Breathing
in America: Diseases, Progress,
and Hope.
moRe on Ats ‘Hill dAy’
At “Hill Day” 2011, ATS members from 17 states traveled
to Capitol Hill to talk with legislators and their staffs
about issues important to the ATS agenda (for more
information, please see the story to the left). Many of the states
represented by ATS advocates are home to thoracic society
chapters, including: Arizona, Colorado, Hawaii, Kentucky,
Michigan, New Mexico, Oregon, Rhode Island and
Washington. This year’s “Hill Day” participants weigh in
on what they thought of the experience below.
“This was the fourth time I’ve participated in this
event and it was—once again—an exciting and
productive day. This year, our focus highlighted
the following incredibly important topics: increased
research funding for the NIH and VA, supporting
the EPA’s authority to ensure clean air, and the
development of a national COPD plan. It felt to me
like our presence on the Hill had an impact.”
–ATS Immediate-Past President J. Randall
Curtis, MD, MPH, representing Washington
“We had a good experience all around. Everyone
was receptive to us, if not fully of our messages. It
was a great learning experience, and I felt like we
were doing something worthwhile!”
–ATS PAR member Regina Vidaver, PhD,
representing Wisconsin
“‘Hill Day’ was an eye-opening experience for me—I
hadn’t done it before. Some legislators were very
receptive and supportive. Representative Price’s
staffer actually voiced our position very eloquently
and passionately before we did. Overall, it was a
very good experience and gave me some insight
into how things work.”
–ATS President-Elect Nicholas Hill, MD,
representing Massachusetts
“It was an excellent experience and extremely
well-organized by the Society’s government
relations office.”
–ATS member Barbara Phillips, MD,
representing Kentucky
“I again had a wonderful experience on the Hill this
week. I am always impressed with the reception we
receive from our representatives. It’s a delight to
spend a day with ATS colleagues from around the
country and have the opportunity to discuss issues
that we all face daily.”
–ATS member Louis Libby, MD,
representing Oregon
AtS 2011 Journal & Magazine Annex
pick up copies of leading medical journals and news magazines, free-ofcharge,
by visiting the ats Journal & magazine annex, which will be located
outside the exhibit Hall in the Colorado Convention Center.
13

14
NEWS
The 18 th annual Methods in Epidemiology, Clinical and
Operations Research (MECOR) in Latin America will
take place November 7 to 12, 2011, at the University
Especialidades Espiritu Santo in Guayaquil, Ecuador.
Jointly sponsored by the Asociación Latinoamericana
del Tórax (ALAT) and the ATS, the MECOR program
encourages physicians, academicians and other healthcare
professionals who are engaged in the clinical practice
of respiratory, critical care and sleep medicine and
related fields concerning public health to develop research
projects describing the burden of lung disease in their
country and then to develop, design and carry out studies
evaluating interventions that are likely to be effective in
those settings.
In 2011, for the second consecutive year, each
course will be led by a Latin American faculty member,
in collaboration with an ATS faculty member, as the
transition of responsibility for the Latin American
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
ALAT/ATS To HoST 18 TH AnnuAL MECoR CouRSE in LATin AMERiCA
MECOR program from the ATS to ALAT continues.
With this transition almost complete, ALAT and the
ATS have pledged to work together to sustain the course
structure and maintain student competencies.
In 2011, the following courses will be offered:
Level 1: “Introduction to Clinical Research
Methods”
Level 2: “Advanced Clinical Methods”
Level 3: “Advanced Clinical Research Methods:
Protocol Development”
Level 4: “Applied Clinical Research Methods:
Data Analysis and Scientific Writing”
Who Should Apply?
Physicians and academicians with an interest in respiratory
medicine who wish to improve their skills in clinical
research and investigation. No prior experience with
research is needed for the level-one course, but applicants
The Foundation of the ATS
SAVE THE DATE
Third annual aTs foundaTion
research program dinner
Saturday, May 14, 2011 denver, COlOradO
For more information on the dinner, visit our Web site at
http://foundation.thoracic.org
or call 212-315-8622
for the level-two course should have research experience
or have attended the introductory MECOR course.
Since all four courses emphasize methods for
quantifying the burden of respiratory disease in Latin
America, preference in selecting applicants and providing
travel awards will be given to individuals with a specific
interest in this area of research.
Why Should I Attend?
MECOR is much more than an annual training course.
It allows attendees to form ongoing relationships with
mentors and provides a forum in which graduates are able
to present their research findings.
How Do I Apply?
Please send initial inquiries to Gaby Patino at gpatinoire@
yahoo.com. Application forms can also be downloaded
from the ATS Web site at www.thoracic.org/globalhealth/mecor-courses/courses.php.
undERwRiTERS
PATRonS
SPonSoR
ats news | vol.37 no.5 | may 2011

NEWS
raC’s va subCommittee sets tHree Key goals
The ATS has long recognized the
importance of the Department
of Veterans Affairs (VA) research
program. In particular, the
VA’s Merit Review and Career
Development Programs, along with
the VA’s affiliated private research
foundations—which permit capture
of indirect costs—have been the
source of substantial support for
ATS members.
Two years ago, the Research Advocacy Committee
(RAC) formed a VA subcommittee with the goal of
increasing ATS member participation in VA research
programs. RAC Chair Landon King, MD, who is the
David Marine Professor of Medicine at Johns Hopkins,
appointed James Brown, MD, who is professor of clinical
medicine at the University of California, San Francisco,
to initiate the effort. Through meetings at the last two
International Conferences, the subcommittee defined
three key advocacy goals:
(1) Improve VA research laboratory infrastructure:
support is needed to upgrade and/or replace
existing VA research laboratories;
(2) Initiate respiratory disease-directed requests
for VA research proposals: veterans would
benefit from research targeted to respiratory
disorders which are prevalent among VA
patients; and
(3) Create accessible databases of funded projects:
if available, these would leverage strengths of the
VA portfolio and increase collaborative research
within the VA, as well as with investigators
outside of the VA.
ATS members elected Thomas
Ferkol, MD, ATS Secretary-
Treasurer for the 2011 to 2012
term. He will be installed in
this position at ATS 2011 on
Tuesday, May 17, during the
ATS Membership Meeting. Dr.
Ferkol is professor of pediatrics,
cell biology, and physiology and
director of the multidisciplinary Division of Pediatric
Allergy, Immunology, and Pulmonary Medicine at the
Washington University School of Medicine. After earning
his medical degree from the Ohio State University College
of Medicine, he completed residency training at the
University of North Carolina at Chapel Hill. He received
his fellowship training in pediatric pulmonology at Case
Western Reserve University and subsequently joined their
pediatric faculty. He moved to Washington University
in 2000, where he has directed the comprehensive Cystic
Fibrosis Center for the past decade.
An American Lung Association Edward Livingston
Trudeau Scholar and recipient of the Cystic Fibrosis
ats news | vol.37 no.5 | may 2011
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
With guidance from Gary Ewart,
senior director of ATS government
relations, and Nuala Moore, senior
ATS legislative representative, several
steps have been taken to advance
these goals. In February, members
of the RAC visited Capitol Hill
and requested that the report from
an internal audit of VA research
infrastructure, commissioned by
Congress in 2006, be completed and released.
“With assistance of Steven Dubinett from UCLA,
who is a member of the ATS’s Section on Thoracic
Oncology, a topic for a potential VA request for proposals
was identified relating to the four-fold increased risk
of lung cancer among patients with COPD,” said Dr.
Brown. “The ATS invited a VA research program leader,
Dr. Ronald Przygodzki, to attend the 2010 International
Conference, and Steve Dubinett included Dr. Przygodzki
as a co-chair of a symposium that explored the links
between the two diseases. At a subsequent meeting of the
VA subcommittee, we discussed each of the three advocacy
goals with Dr. Przygodzki.”
For 10 years, the ATS’s government relations office
has worked to raise Congressional awareness of the VA
research program’s value, and the efforts of Dr. Brown
and the VA subcommittee have magnified the
importance of this effort. To help advance these goals
and develop new ones, Drs. King and Brown invite all
ATS members to attend the VA Subcommittee meeting
on Sunday, May 15, from noon to 1:30 p.m. during the
2011 International Conference. The meeting will take
place in Room 204 on street level of the Colorado
Convention Center.
Landon King, MD James Brown, MD
FerKol eleCted ats seCretary-treasurer
Foundation (CFF) LeRoy Matthew’s Physician-Scientist
Award, his research has focused on characterizing
genetic and molecular factors that contribute to airway
involvement in cystic fibrosis and primary ciliary
dyskinesia. With support from the NIH, CFF and
March of Dimes, he and his collaborators have identified
potential therapeutic targets for suppurative lung diseases
and developed novel approaches for drug delivery.
He is an investigator for the NIH-supported Genetic
Diseases of Mucociliary Clearance Consortium, and has
assembled a clinical, biomedical and engineering research
collaborative at Washington University, studying genetic
andphenotypic spectrum of ciliopathies.
Dr. Ferkol has been a member of several scientific
review groups, including the NIH Gene and Drug
Delivery Study Section, ATS Career Development Grants
Review Committee, CFF Research Development Program
Review Committee and CFF Functional Genomics Review
Committee. He is a current member of the American
Board of Pediatrics Subboard of Pediatric Pulmonology,
and will become the first pediatric specialist to serve as
president of the ATS.
What’s New
in the AJRCCM
the april 15, 2011,
issue of the American
Journal of Respiratory
and Critical Care
Medicine features
a concise clinical
review by asha
anandaiah,
Keertan dheda,
Joseph Keane,
Henry Koziel,
david a. J. Moore, and Naimish
R. Patel, which focuses on novel
developments in the epidemic of
HIv and tB co-infection. this issue
also includes another installment
of the “Images in Pulmonary,
critical care, Sleep Medicine and
the Sciences” that illustrates an
uncommon cause of pulmonary
hypertension.
Learn more at
http://ajrccm.atsjournals.org.
neW ats report FoCuses
on possible Causes oF ips
(continued from page 5)
most developed therapeutic strategy is that for blocking
TNF signaling with etanercept, which is currently being
evaluated in clinical trials.”
“IPS remains a frequently fatal complication that
limits the broader use of allogeneic HSCT as a successful
treatment modality,” she continued. “Faced with the
clinical syndrome of IPS, one can categorize the disease
entity with the appropriate
tools, although cases of
unclassifiable IPS will
remain. Importantly, new
laboratory insights are
currently being translated
to the clinic and will likely
prove important to the
development of future
strategies to prevent or
treat this serious disorder.” Angela Panoskaltsis-Mortari, MD
15

16
NEWS
coNfERENcES, couRSES & MEEtiNgS
Activities sponsored or endorsed by the ATS and its chapters are listed in bold.
date & plaCe
May 1 to 4
Cambridge,
Massachusetts
May 6 to 7
Coventry, United
Kingdom
May 11 to 13
Atlanta, Georgia
may 13 to 18
denver, Colorado
May 20 to 22
Münster, Germany
June 8 to 11
Aspen, Colorado
June 9 to 10
Paris, France
June 13 to 17
Boston,
Massachusetts
title
“Pulmonary and Critical Care Medicine
Course,” sponsored by Harvard
Medical School and Massachusetts
General Hospitals
“The Annual Association of Respiratory
Nurse Specialists Conference”
“Approaching the Clinic: Nitrite and
Nitrate Pathophysiology and Therapy
Conference”
“2011 international Conference,”
sponsored by the american
thoracic society
“International Conference on Inherited
Disorders of Muco-Ciliary Clearance,”
sponsored by Universitätsklinikum
Münster
54 th Annual Thomas L. Petty Aspen
Lung Conference: “COPD and Lung
Cancer: Common Pathogenesis,
Shared Clinical Challenges”
“1 st International Paris International
Spring Conference on Intensive Care,”
sponsored by the Société de Réanimation
de Langue Française
“Comprehensive Industrial Hygiene:
The Application of Basic Principles,”
sponsored by the Harvard School of
Public Health Center for Continuing
Professional Education
president’s symposium
a m e r i c a n t h o r a c i c s o c i e t y • http://www.thoracic.org
ContaCt
czaniewskijuzyca@partners.org
Barbara Hamilton
barbara@djcassociates.co.uk
www.strategicresults.com/
nitrite2011
(212) 315-8658
conference@thoracic.org
http://conference.thoracic.org
hotel@agora-muenster.de
www.agora-muenster.de
(303) 724-6038
www.aspenlungconference.org
www.pic-srlf.fr
https://ccpe.sph.harvard.edu/cih
(continued from page 2)
“Indoor air pollution, for instance, has occurred since humans first used fire in enclosed
spaces, but, as former ATS President William J. Martin will tell you, only with effective
world health leadership is the problem being addressed.”
Scheduled topics and speakers include:
8:15 a.m.: Defining Research Questions: Strategic Approaches to Scientific
Priorities in Lung Health—S. Shurin, MD, Bethesda, MD
8:45 a.m.: Developing Great Leaders in Global Health: Experience and Lessons
from the Fogarty International Center, NIH—J. G. Breman, MD,
Bethesda, MD
9:15 a.m.: Leadership in Health and Development—E. Baris, MD, Washington, DC
9:45 a.m.: How Leadership Makes a Difference—W. J. Martin, MD, Bethesda, MD
10:15 a.m.: Working with the Field—L. Ditiu, MD, Geneva, Switzerland
“The world is becoming a smaller place, and the impact of diseases in one part of the
world has larger implications in other parts of the world,” said Marc Moss, MD, professor
of medicine at the University of Colorado, Denver, who chairs the ATS International
Conference Committee. “We can learn from other international scientists and clinicians
who have experience with treating lung diseases, and extrapolate their knowledge to help
our patients.”
Ats foundation
Reseach Program
Apply for the Ats/foundation for sarcoidosis
Research grant
(one grant is available)
APPliCAtion deAdline:
June 15, 2011, at 9 a.m. Eastern Time
The focus of this research grant, which is co-funded by the ATS
Foundation and the Foundation for Sarcoidosis Research, is
programs with a high likelihood of advancing the understanding
of the pathogenesis, epidemiology or treatment of sarcoidosis.
Applicants may request up to $40,000 per year for two years for
salaries, supplies or a combination of the two.
A primary goal of the ATS Foundation Research Program is to
enable new faculty-level investigators to transition to careers
as established investigators. The Society strongly encourages
partnerships between junior and senior researchers, particularly
for new investigators who completed their training within the last
five years.
Both U.S.- and non-U.S.-based investigators are encouraged to
apply. At least one of the investigators must be an ATS member at
the time of application and the principal investigator must be an ATS
member at the time that the grant is awarded. Indirect costs will not
be paid to the sponsoring institution. For more information, please
visit the ATS Web site at www.thoracic.org.
To apply, please visit the proposalCENTRAL Web site at
https://proposalcentral.altum.com.
don’t miss these networking
opportunities at ats 2011
this year, conference attendees will have two new
and engaging tools to help them to connect at the
atS 2011 International conference in denver:
• “my ATS 2011” by zerista is a desktop and mobile
software through which attendees can see who else will
be at the conference, make connections and network
before, during and after the conference.
• Alumni and group Lounges are meeting rooms that
will be available for in-person get-togethers, reunions or
receptions from 8 a.m. to 5 p.m. from Sunday, May 15,
to tuesday, May 17, during atS 2011.
For more information, contact
stacy blackshaw at sblackshaw@thoracic.org.
ats news | vol.37 no.5 | may 2011